data_2lif_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lif _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.98 0.419 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.89 103.39 11.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.679 -0.638 . . . . 0.0 110.248 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.23 -121.42 1.96 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -121.84 134.22 24.59 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.865 . . . . 0.0 110.322 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.96 70.62 5.4 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.777 1.409 . . . . 0.0 110.954 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -94.13 -33.02 13.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 39.0 m -57.11 -28.4 62.63 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.037 -0.415 . . . . 0.0 111.037 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.96 -42.52 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.63 -33.82 69.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.94 -47.17 72.49 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.81 -43.03 84.89 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.42 96.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.64 -41.48 92.56 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.464 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 9.1 tp -59.74 -37.52 79.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.898 -0.502 . . . . 0.0 109.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.8 t -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 29.0 m -72.87 -41.59 64.57 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.464 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.0 pt -80.07 -8.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.725 -0.609 . . . . 0.0 112.33 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.7 t -102.23 2.93 37.74 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.989 . . . . 0.0 111.787 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.53 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 63.8 t -73.37 -50.93 5.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 120.54 -1.35 . . . . 0.0 111.083 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.3 Cg_endo -75.3 -7.45 18.9 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.022 1.011 . . . . 0.0 113.259 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.3 m -64.32 -31.46 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.053 -1.029 . . . . 0.0 110.795 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m -64.4 -44.11 92.31 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.577 ' HA ' HG23 ' A' ' 194' ' ' VAL . . . -65.18 -28.75 69.61 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.171 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.33 66.11 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.785 -0.572 . . . . 0.0 109.772 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.08 -32.89 44.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.641 . . . . 0.0 110.974 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 191' ' ' ALA . 36.0 m -78.74 -11.05 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.415 -0.803 . . . . 0.0 112.097 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.002 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.491 0.662 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -155.74 155.2 32.69 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.595 -0.691 . . . . 0.0 110.437 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.28 116.34 4.8 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -110.44 110.33 57.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.644 -0.916 . . . . 0.0 110.754 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.98 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.404 1.213 . . . . 0.0 110.359 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -95.76 -28.3 14.83 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.7 m -66.25 -19.6 65.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.096 -0.377 . . . . 0.0 110.903 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.53 -39.6 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 118.934 0.788 . . . . 0.0 109.558 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -75.97 -33.16 59.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -67.47 -47.18 70.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.37 -43.69 85.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.69 95.16 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.53 -39.08 81.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.523 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.8 OUTLIER -59.35 -37.97 79.21 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.858 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.4 t -61.27 -36.18 79.32 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.478 -0.764 . . . . 0.0 110.164 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.2 m -75.11 -35.06 61.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.183 -0.323 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.523 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 10.7 pt -89.25 -4.71 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.549 -0.72 . . . . 0.0 112.772 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 m -48.51 -41.2 29.31 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.245 -0.909 . . . . 0.0 112.144 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.52 ' HB ' ' CD ' ' A' ' 188' ' ' PRO . 83.9 t -61.87 -62.01 6.67 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.482 -0.761 . . . . 0.0 110.512 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.52 ' CD ' ' HB ' ' A' ' 187' ' ' VAL . 43.6 Cg_endo -64.26 -24.36 65.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 122.938 0.967 . . . . 0.0 111.824 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.0 t -63.66 -51.66 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.7 m -66.46 -31.94 73.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.115 -0.365 . . . . 0.0 110.472 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -74.55 -34.38 62.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.932 -0.48 . . . . 0.0 110.328 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.99 62.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.188 -0.32 . . . . 0.0 110.727 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.74 34.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.293 -0.88 . . . . 0.0 110.505 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.13 -41.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.836 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.15 159.11 35.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.787 -0.57 . . . . 0.0 110.634 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -106.0 58.86 0.43 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.21 120.86 28.9 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 122.061 -0.67 . . . . 0.0 110.299 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.37 -171.39 1.15 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 124.002 1.527 . . . . 0.0 111.244 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.0 t80 69.18 0.27 2.77 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.035 -0.415 . . . . 0.0 111.837 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -42.87 66.49 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.5 tt -64.32 -33.22 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -68.41 -36.36 78.99 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.454 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -65.28 -41.26 94.35 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.42 -45.91 61.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.86 86.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.444 ' O ' HG12 ' A' ' 185' ' ' ILE . 4.2 tp -72.3 -37.04 69.07 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -50.87 -43.08 59.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.97 -0.456 . . . . 0.0 110.841 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.2 t -62.53 -30.03 71.0 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.757 -0.59 . . . . 0.0 110.465 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 83.4 m -76.76 -34.56 58.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 181' ' ' LEU . 19.7 mm -70.16 -33.92 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.766 -0.584 . . . . 0.0 110.456 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.2 p -69.99 -23.17 63.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.731 -0.606 . . . . 0.0 111.826 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.48 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 99.4 t -61.13 -57.23 27.54 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 121.284 -0.885 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 44.3 Cg_endo -65.99 -28.44 49.73 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.067 1.035 . . . . 0.0 110.947 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.45 -43.39 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.2 m -62.73 -37.97 88.66 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.062 0.458 . . . . 0.0 109.766 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.04 -29.08 70.25 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.51 -35.61 27.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 110.451 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -38.61 53.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.635 -0.666 . . . . 0.0 111.462 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.91 -35.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.399 -0.813 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.728 179.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.857 0.36 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -100.72 18.25 19.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.455 -0.778 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.37 -95.99 0.32 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -121.02 77.38 31.44 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.985 -0.715 . . . . 0.0 109.262 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.78 58.77 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.27 1.313 . . . . 0.0 111.735 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -100.13 -8.44 23.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.369 -0.832 . . . . 0.0 110.718 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.5 t -59.29 -30.67 68.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.8 pp -59.44 -40.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -34.03 60.35 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 27.8 mt -64.66 -41.15 96.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -44.84 68.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.96 97.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.73 -38.12 70.49 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.806 -0.559 . . . . 0.0 109.778 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.49 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.0 OUTLIER -62.41 -40.11 95.44 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.728 -0.608 . . . . 0.0 110.454 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.0 t -60.51 -36.67 78.93 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.767 -1.208 . . . . 0.0 110.077 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.03 -42.09 69.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.155 -0.341 . . . . 0.0 110.251 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.49 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -81.94 -18.11 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.627 -0.671 . . . . 0.0 112.095 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 85.3 m -86.3 -5.64 59.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.418 -0.801 . . . . 0.0 111.119 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.467 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 52.2 t -51.15 -51.41 68.32 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.728 -1.233 . . . . 0.0 111.636 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.2 Cg_endo -72.21 -3.51 13.45 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 O-C-N 123.19 1.1 . . . . 0.0 113.577 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -29.19 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.106 -0.996 . . . . 0.0 111.23 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.6 m -58.99 -44.56 91.64 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -65.55 -38.84 90.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.31 -34.93 69.23 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -78.75 -32.59 46.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.747 -0.596 . . . . 0.0 110.153 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.9 -40.37 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.449 -0.782 . . . . 0.0 109.46 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.088 0.471 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.95 122.97 34.96 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.275 -0.891 . . . . 0.0 110.502 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -87.52 -59.09 1.76 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.07 84.0 32.37 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.654 -0.91 . . . . 0.0 109.376 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.86 -31.28 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.645 1.34 . . . . 0.0 111.912 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.15 -42.06 89.54 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.717 -0.614 . . . . 0.0 111.172 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.0 p -62.58 -27.92 69.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.017 -0.427 . . . . 0.0 111.344 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.39 -43.5 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -30.84 67.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -67.34 -45.88 75.1 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.39 -43.76 69.38 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.03 96.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.456 ' O ' HG12 ' A' ' 185' ' ' ILE . 1.3 tt -68.12 -40.66 82.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.87 -40.12 75.57 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.863 -0.523 . . . . 0.0 110.146 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 t -62.48 -37.19 85.02 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.6 m -68.83 -34.19 75.08 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 181' ' ' LEU . 14.9 mm -67.25 -33.56 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.642 -0.661 . . . . 0.0 109.555 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 m -67.59 -29.18 68.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.934 -0.479 . . . . 0.0 110.853 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.454 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 63.6 t -54.71 -59.08 11.46 Favored Pre-proline 0 N--CA 1.506 2.348 0 O-C-N 121.567 -0.708 . . . . 0.0 111.669 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 46.9 Cg_endo -67.75 -32.51 29.84 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 O-C-N 122.994 0.997 . . . . 0.0 111.29 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.85 -43.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 m -69.52 -31.24 69.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.108 -0.37 . . . . 0.0 110.286 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.13 68.13 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.761 -0.587 . . . . 0.0 110.209 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -87.32 -36.93 17.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.847 -0.533 . . . . 0.0 109.952 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.61 -40.83 98.17 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.635 -0.666 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.91 -34.39 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.724 -0.61 . . . . 0.0 110.481 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.148 179.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.903 0.382 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 175.49 7.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.786 -0.571 . . . . 0.0 110.71 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 147.65 -134.94 5.37 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.37 74.13 30.58 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.635 -0.92 . . . . 0.0 110.206 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.67 168.1 24.25 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.677 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.9 t80 63.13 7.96 3.04 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.9 p -84.79 -40.96 16.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.846 -1.159 . . . . 0.0 109.44 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.5 -34.12 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.84 -33.39 57.91 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.0 mt -62.7 -41.3 99.06 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mp -73.47 -45.38 54.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.19 84.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.453 ' O ' HG12 ' A' ' 185' ' ' ILE . 5.2 tt -76.79 -35.89 57.35 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.59 -40.01 71.48 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.814 -0.554 . . . . 0.0 111.106 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.36 73.98 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 3.6 t -76.16 -9.73 58.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.975 -0.453 . . . . 0.0 110.806 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 181' ' ' LEU . 38.0 mm -101.34 -38.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.165 -0.96 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.434 ' HA ' HG22 ' A' ' 189' ' ' VAL . 12.3 t -67.01 -32.27 73.38 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.016 -0.428 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.451 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 49.4 t -67.09 -53.98 22.44 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.212 -0.93 . . . . 0.0 111.417 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.451 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -70.28 -2.9 11.3 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.102 1.201 . . . . 0.0 114.24 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.434 HG22 ' HA ' ' A' ' 186' ' ' THR . 23.5 t -56.23 -49.36 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 119.933 1.242 . . . . 0.0 110.76 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.4 m -60.17 -38.93 84.72 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.98 -0.45 . . . . 0.0 109.989 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.477 ' HA ' HG23 ' A' ' 194' ' ' VAL . . . -66.79 -37.42 84.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.38 73.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -25.5 46.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.795 -0.566 . . . . 0.0 110.984 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' HA ' ' A' ' 191' ' ' ALA . 32.6 m -97.0 0.67 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.405 -0.81 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt . . . . . 0 N--CA 1.505 2.281 0 O-C-N 121.418 -0.801 . . . . 0.0 111.896 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -105.09 144.05 32.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.895 -0.503 . . . . 0.0 110.128 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.04 65.49 3.96 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -121.77 88.48 47.22 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.931 -0.746 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.24 -7.28 19.56 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.631 1.332 . . . . 0.0 112.38 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.28 18.4 15.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.326 -0.858 . . . . 0.0 111.133 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 p -89.22 -24.44 22.13 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.018 -1.051 . . . . 0.0 110.77 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.5 -46.82 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -72.9 -33.04 65.75 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.8 tp -65.8 -46.43 78.72 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.9 tp -69.27 -43.44 73.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.43 92.54 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tp -74.98 -33.99 61.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.32 -38.38 83.53 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.667 -0.646 . . . . 0.0 110.12 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.1 t -57.36 -39.0 75.05 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.439 0.638 . . . . 0.0 109.768 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.11 -13.97 62.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.714 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 38.0 mm -97.53 -33.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.096 -1.002 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.8 m -73.26 -35.78 66.25 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.049 -0.407 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 42.7 t -59.62 -53.73 62.85 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.8 Cg_endo -72.9 -3.42 13.56 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.154 1.081 . . . . 0.0 113.222 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.2 p -56.99 -30.14 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.102 -0.999 . . . . 0.0 111.444 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 11.7 m -61.28 -43.15 99.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.655 -0.653 . . . . 0.0 109.414 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.74 70.65 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.53 69.6 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -82.65 -32.72 28.08 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.583 -0.698 . . . . 0.0 109.716 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.1 t -78.49 -52.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.638 -0.664 . . . . 0.0 109.213 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.798 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.46 34.68 3.92 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.586 -0.697 . . . . 0.0 111.072 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.88 176.88 30.8 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -120.84 80.63 33.27 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.658 -0.907 . . . . 0.0 109.673 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.48 179.87 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.494 1.26 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.78 8.74 2.54 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 58.9 m -97.37 -30.07 13.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.226 -0.921 . . . . 0.0 110.464 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -61.72 -42.05 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.28 -30.25 57.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.772 -0.58 . . . . 0.0 109.871 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.7 mp -70.67 -44.59 66.73 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.41 -43.49 66.67 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.51 97.16 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.75 -36.56 75.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.37 -39.11 86.04 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.715 -0.616 . . . . 0.0 109.766 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.2 t -61.12 -32.86 72.54 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.436 0.636 . . . . 0.0 109.523 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.72 -21.91 54.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.071 -0.393 . . . . 0.0 110.596 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 37.4 mt -88.74 -31.43 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.183 -0.948 . . . . 0.0 110.46 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.9 p -73.9 -32.29 63.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.905 -0.497 . . . . 0.0 111.718 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.445 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 34.2 t -60.03 -53.94 60.29 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.177 -0.952 . . . . 0.0 111.477 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.5 Cg_endo -71.82 -4.59 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.025 1.013 . . . . 0.0 113.408 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.85 -31.2 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.947 -1.095 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.5 m -67.51 -41.41 84.49 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.484 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -70.41 -29.89 66.62 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 120.851 0.358 . . . . 0.0 110.306 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -67.76 -32.7 73.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.876 -0.515 . . . . 0.0 110.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -92.04 -23.95 19.34 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.509 -0.744 . . . . 0.0 111.844 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.484 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -86.17 -1.47 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.03 -1.044 . . . . 0.0 111.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.177 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -161.97 -178.86 6.72 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.97 0.414 . . . . 0.0 110.484 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.48 -122.64 4.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -121.54 134.95 24.72 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.855 . . . . 0.0 110.361 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.37 72.02 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.758 1.399 . . . . 0.0 110.652 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -111.25 -23.64 10.72 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.278 -0.888 . . . . 0.0 111.811 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.8 m -60.18 -35.1 74.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 44.8 pt -63.24 -36.64 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -73.44 -32.69 64.52 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 14.4 mt -63.43 -42.51 98.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.4 tp -72.24 -45.09 61.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.13 95.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tp -72.32 -33.49 67.4 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.1 OUTLIER -54.35 -45.36 72.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.902 -0.499 . . . . 0.0 109.993 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.1 t -65.18 -34.44 78.38 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.15 -29.97 62.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.239 -0.288 . . . . 0.0 110.879 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.414 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 3.1 pt -93.81 -8.38 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.534 -0.729 . . . . 0.0 112.11 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.2 m -70.63 -46.39 63.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.131 -0.98 . . . . 0.0 109.813 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.465 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 72.3 t -60.75 -52.08 75.07 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.414 -0.803 . . . . 0.0 110.905 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.2 Cg_endo -70.23 -3.31 12.07 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.009 1.139 . . . . 0.0 113.589 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.11 -26.96 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.064 -1.023 . . . . 0.0 111.322 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.3 m -64.66 -41.87 95.79 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.538 -0.726 . . . . 0.0 109.304 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.61 70.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.901 0.382 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.44 60.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.783 -0.573 . . . . 0.0 110.424 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -42.27 68.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.614 -0.679 . . . . 0.0 111.111 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.16 -35.49 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.233 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 158.64 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.504 -0.747 . . . . 0.0 110.307 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -66.19 -74.84 0.48 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.27 109.73 57.63 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.878 -0.778 . . . . 0.0 109.758 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.88 51.1 3.07 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.34 1.36 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -104.02 4.5 34.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.208 -0.933 . . . . 0.0 111.545 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 12.9 p -79.86 -23.83 41.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.305 -0.872 . . . . 0.0 110.981 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 mt -56.95 -48.57 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.824 -0.548 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.54 -30.16 61.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.713 -0.617 . . . . 0.0 109.635 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 14.4 mt -69.35 -42.83 74.73 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.79 -43.0 73.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.26 90.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -66.62 -37.34 84.65 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.488 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 2.3 tt -61.05 -39.71 90.88 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.7 t -62.53 -35.59 79.89 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.254 -0.903 . . . . 0.0 109.781 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 46.5 m -75.94 -32.74 59.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.132 -0.355 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.488 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -93.38 -8.07 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.442 -0.786 . . . . 0.0 112.315 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.4 m -84.62 -41.8 16.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.168 -0.958 . . . . 0.0 110.323 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.6 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 35.7 m -63.74 -36.61 22.59 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.034 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.6 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.9 Cg_endo -73.65 -11.3 24.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 CA-C-N 119.872 0.99 . . . . 0.0 112.236 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -29.14 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.291 -0.88 . . . . 0.0 111.12 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 71.1 m -60.52 -40.99 93.5 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.206 0.527 . . . . 0.0 109.764 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.473 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -66.87 -30.41 70.57 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.02 -28.06 64.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.874 -0.516 . . . . 0.0 110.207 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -89.78 -33.13 16.65 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.416 -0.803 . . . . 0.0 110.495 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 33.5 m -79.63 -1.86 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.401 -0.812 . . . . 0.0 112.123 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.474 179.809 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.382 0.611 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -153.66 175.94 12.67 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.488 -0.757 . . . . 0.0 110.5 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.25 144.34 13.78 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -121.75 134.72 24.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.887 . . . . 0.0 109.888 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.13 51.74 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.63 1.331 . . . . 0.0 112.119 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -103.86 -34.55 8.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.964 -1.085 . . . . 0.0 110.226 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.2 m -60.55 -30.05 69.53 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.899 -0.501 . . . . 0.0 110.659 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 tp -58.61 -39.01 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 122.068 -0.395 . . . . 0.0 110.173 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -78.28 -32.05 49.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.529 -0.732 . . . . 0.0 109.099 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.25 -45.19 73.87 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -41.12 73.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.61 -45.13 95.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.82 -34.78 69.6 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.36 -39.4 90.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.645 -0.659 . . . . 0.0 110.073 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -57.87 -38.74 76.27 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.711 -0.618 . . . . 0.0 109.706 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.71 -25.66 68.04 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.172 -0.33 . . . . 0.0 110.62 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 37.5 mm -86.41 -40.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.521 -0.737 . . . . 0.0 110.175 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 56.9 m -73.64 -32.55 64.08 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.008 -0.433 . . . . 0.0 111.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 5.5 t -53.08 -55.97 28.51 Favored Pre-proline 0 N--CA 1.507 2.411 0 CA-C-N 119.429 1.013 . . . . 0.0 111.17 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.08 -31.4 36.84 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.26 1.137 . . . . 0.0 111.13 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -43.4 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.5 m -61.11 -40.68 94.69 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.552 ' HA ' HG23 ' A' ' 194' ' ' VAL . . . -64.67 -32.34 73.96 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.144 -0.347 . . . . 0.0 110.212 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.91 68.58 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -36.23 65.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.933 -0.48 . . . . 0.0 110.682 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.552 HG23 ' HA ' ' A' ' 191' ' ' ALA . 31.1 m -76.3 -10.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.16 -0.962 . . . . 0.0 111.749 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.477 -0.764 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 42.2 mttt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 132.83 51.88 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.554 -0.717 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.66 -174.3 30.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -91.53 134.86 28.65 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.686 -0.89 . . . . 0.0 109.966 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.86 176.24 9.26 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.722 1.38 . . . . 0.0 111.493 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.14 13.64 5.95 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.106 -0.371 . . . . 0.0 111.815 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.9 p -96.86 -30.75 12.96 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.411 -0.806 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tp -55.25 -38.12 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 122.199 -0.313 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -74.59 -33.41 62.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.57 -0.706 . . . . 0.0 109.55 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -45.07 68.56 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -67.48 -43.73 80.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.2 97.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.14 -40.11 90.37 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.59 -38.15 83.69 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.701 -0.624 . . . . 0.0 109.817 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.7 t -62.83 -37.35 86.44 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -67.91 -13.7 62.37 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.154 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 62.7 mt -97.18 -39.67 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 30.0 m -72.87 -33.35 66.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.083 -0.386 . . . . 0.0 111.795 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.461 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 41.8 t -61.58 -53.72 58.78 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.86 -1.15 . . . . 0.0 111.468 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.461 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -72.62 -8.8 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.062 1.033 . . . . 0.0 113.333 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -65.06 -28.97 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.076 -1.015 . . . . 0.0 111.186 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 m -63.44 -38.9 92.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.732 -0.605 . . . . 0.0 109.937 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.84 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.66 70.83 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.228 -0.295 . . . . 0.0 110.438 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -85.99 -21.78 27.65 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.305 -0.872 . . . . 0.0 110.473 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.6 t -90.49 -53.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.365 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 156.99 40.05 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.694 -0.629 . . . . 0.0 109.675 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 178.1 -63.66 0.08 OUTLIER Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.964 -1.113 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.78 133.6 69.85 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.597 -0.943 . . . . 0.0 111.131 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . 0.47 ' HB2' HD11 ' A' ' 176' ' ' ILE . 50.7 Cg_endo -84.31 72.06 5.24 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.509 1.473 . . . . 0.0 110.608 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -100.29 -16.9 17.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.432 -0.792 . . . . 0.0 112.282 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.488 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 46.3 m -73.5 -21.4 60.42 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.255 -0.903 . . . . 0.0 112.114 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 173' ' ' PRO . 34.6 mt -58.39 -47.74 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.776 -0.578 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -78.56 -27.28 45.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.488 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 13.2 mt -68.6 -47.28 67.12 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -42.91 86.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.16 -47.73 84.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.7 tp -68.14 -35.15 77.63 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.647 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.475 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.639 -0.663 . . . . 0.0 109.985 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.7 t -66.5 -35.14 79.51 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.367 -0.833 . . . . 0.0 109.817 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 7.7 t -74.34 -41.67 60.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.985 -0.447 . . . . 0.0 109.985 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.475 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.3 pp -79.1 -20.49 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.535 -0.728 . . . . 0.0 112.131 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.407 ' HB ' ' O ' ' A' ' 182' ' ' LEU . 2.8 t -77.4 -17.71 57.92 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.15 -0.969 . . . . 0.0 111.878 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.48 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 86.9 t -59.72 -54.79 52.25 Favored Pre-proline 0 N--CA 1.505 2.32 0 O-C-N 121.066 -1.021 . . . . 0.0 110.75 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.48 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -67.55 -29.37 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.111 1.058 . . . . 0.0 110.977 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.59 -43.36 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.8 m -62.8 -39.16 93.41 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.056 0.455 . . . . 0.0 109.775 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.507 ' HA ' HG21 ' A' ' 194' ' ' VAL . . . -67.05 -24.27 65.96 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.119 -0.363 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -78.35 -38.2 42.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 109.476 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -74.14 -35.67 64.09 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.522 -0.736 . . . . 0.0 110.562 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -73.39 -9.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.458 -0.776 . . . . 0.0 111.59 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.033 179.782 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.96 74.98 1.54 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.549 -0.719 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.83 59.87 6.18 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.01 131.79 55.75 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.437 -1.037 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -82.65 78.04 3.49 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.898 1.473 . . . . 0.0 111.063 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -78.06 -35.77 49.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -0.81 . . . . 0.0 110.48 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -31.39 65.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.977 -0.452 . . . . 0.0 110.935 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 mm -60.77 -43.12 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.89 -31.32 67.93 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -42.56 90.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.572 -0.705 . . . . 0.0 109.555 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.78 -44.69 69.6 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.8 98.32 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.431 ' O ' HG12 ' A' ' 185' ' ' ILE . 3.2 tm? -67.07 -43.06 83.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tt -58.28 -37.78 75.69 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.956 -0.465 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.7 t -63.19 -39.23 94.04 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.2 m -67.57 -13.38 62.01 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 181' ' ' LEU . 43.1 mm -98.12 -35.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.1 m -76.47 -37.68 56.53 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.609 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.6 m -68.25 -38.96 14.61 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.816 -1.178 . . . . 0.0 113.478 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.609 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.4 Cg_endo -71.55 -38.12 4.79 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 119.798 0.963 . . . . 0.0 111.485 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 -33.41 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.141 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 m -69.85 -40.01 76.06 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 195' ' ' LYS . . . -65.71 -46.29 79.52 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.59 65.35 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 120.681 0.277 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.82 56.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.36 -54.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.516 -0.74 . . . . 0.0 109.58 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.57 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.097 0.475 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttm 51.23 59.19 4.78 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.589 -0.695 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.51 146.52 5.41 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -81.77 135.27 49.14 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.853 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.18 67.94 7.52 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.723 1.381 . . . . 0.0 111.065 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.47 -21.17 61.26 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.322 -0.861 . . . . 0.0 111.126 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -61.78 -18.99 61.96 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.8 mm -58.35 -49.29 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -80.05 -28.79 39.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.886 -0.509 . . . . 0.0 109.669 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 3.5 mm? -67.77 -43.44 79.8 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.45 -41.33 72.95 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.22 95.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -37.34 70.14 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 25.1 tp -60.41 -36.95 79.32 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -37.43 81.62 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.2 -16.22 62.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.035 -0.416 . . . . 0.0 110.561 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 57.3 mt -95.07 -36.0 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 110.385 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 t -75.14 -19.16 60.03 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.688 -0.632 . . . . 0.0 112.537 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.405 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 24.2 t -75.28 -55.09 2.28 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 120.924 -1.11 . . . . 0.0 110.82 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -68.08 -28.8 34.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 122.963 0.98 . . . . 0.0 112.699 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.8 p -63.85 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.624 -0.673 . . . . 0.0 110.679 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.8 m -64.36 -43.52 94.28 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.439 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -72.08 -32.63 67.22 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.32 71.95 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.772 -0.58 . . . . 0.0 109.962 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -75.95 -37.3 58.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.786 -0.571 . . . . 0.0 109.633 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -91.79 1.73 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.506 2.355 0 O-C-N 121.39 -0.819 . . . . 0.0 112.145 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.413 0.625 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -160.88 130.68 4.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.53 50.34 55.42 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -105.66 134.38 19.74 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.767 -0.843 . . . . 0.0 109.894 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.91 63.68 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.913 1.48 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -116.38 -20.0 9.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.27 -0.894 . . . . 0.0 111.85 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.3 m -58.78 -34.35 71.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.668 -0.645 . . . . 0.0 110.967 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 mt -64.17 -41.12 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.44 -32.09 66.01 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.45 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 27.9 mt -62.76 -44.82 95.2 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -44.65 71.38 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.58 94.63 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.19 -34.01 65.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.877 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.503 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.11 -41.84 93.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -61.93 -34.67 76.52 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.231 -0.918 . . . . 0.0 109.678 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 43.8 m -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.244 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.503 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -96.85 -17.64 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.286 -0.883 . . . . 0.0 112.152 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.7 m -74.45 -40.43 61.91 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.365 -0.834 . . . . 0.0 109.96 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 69.2 t -59.63 -52.46 73.81 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.495 -0.753 . . . . 0.0 111.164 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.8 Cg_endo -71.09 -3.27 12.54 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 120.977 1.118 . . . . 0.0 113.731 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.73 -28.86 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 119.715 1.143 . . . . 0.0 111.173 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.2 m -61.4 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -84.56 -13.37 51.97 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -77.89 -44.93 25.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.447 -0.783 . . . . 0.0 110.32 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.85 -32.88 71.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.536 -0.728 . . . . 0.0 110.862 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.3 m -81.28 -2.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.557 -0.715 . . . . 0.0 111.845 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.8 -1.095 . . . . 0.0 109.988 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.864 0.364 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -95.74 128.67 42.82 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.25 70.73 0.33 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -121.02 127.78 26.05 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.973 -0.722 . . . . 0.0 109.972 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.17 177.09 9.08 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.864 1.455 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.6 t80 63.59 9.43 4.27 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.957 -0.464 . . . . 0.0 112.085 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.414 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 1.7 t -92.23 -27.4 17.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.818 -1.176 . . . . 0.0 109.901 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.42 -41.01 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -75.76 -30.36 59.15 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 2.4 mm? -67.0 -44.88 79.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.33 -42.59 75.12 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.93 92.66 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.35 -38.49 91.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.437 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.3 OUTLIER -58.76 -38.82 79.29 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -67.73 -34.94 77.84 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.573 -0.705 . . . . 0.0 109.724 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.1 t -75.12 -34.05 61.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.927 -0.483 . . . . 0.0 110.336 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.437 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.6 pp -89.2 -7.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.524 -0.735 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.1 t -95.68 -24.91 16.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 111.456 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.57 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.2 m -73.25 -32.71 1.73 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 120.964 -1.085 . . . . 0.0 112.706 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.57 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 119.677 0.921 . . . . 0.0 111.629 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.52 -29.83 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.853 -0.529 . . . . 0.0 110.583 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 m -67.69 -36.27 80.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.641 -0.662 . . . . 0.0 109.266 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.564 ' HA ' HG23 ' A' ' 194' ' ' VAL . . . -74.36 -13.5 60.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.139 -0.35 . . . . 0.0 111.343 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.38 -45.65 62.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.339 -0.851 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -72.4 -30.0 64.25 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.712 -0.618 . . . . 0.0 111.602 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 191' ' ' ALA . 35.1 m -81.4 -1.22 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.282 -0.886 . . . . 0.0 112.155 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.316 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.836 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -80.48 79.84 7.02 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.519 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.39 -70.84 0.11 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -121.5 83.62 41.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.85 -0.794 . . . . 0.0 110.064 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.48 -172.75 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.726 1.382 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.11 13.54 4.78 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.08 -31.9 12.25 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -0.908 . . . . 0.0 110.314 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.7 -38.36 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 122.079 -0.388 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.83 -33.87 64.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.9 -41.54 97.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.84 -44.39 85.69 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.86 97.87 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.61 -40.44 96.93 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 185' ' ' ILE . 1.4 mp -64.1 -30.5 71.56 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 122.142 -0.348 . . . . 0.0 111.414 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -74.01 -33.92 63.96 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.983 -1.073 . . . . 0.0 109.209 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.37 -43.22 61.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.135 -0.353 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 182' ' ' LEU . 2.3 pp -67.15 -23.79 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.688 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 m -76.24 -25.93 55.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.433 -0.792 . . . . 0.0 110.371 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.434 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 94.4 t -56.34 -55.11 45.74 Favored Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.27 -0.894 . . . . 0.0 110.712 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 43.9 Cg_endo -66.02 -26.24 51.03 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.06 1.032 . . . . 0.0 110.996 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.57 -43.95 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -34.46 78.46 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.059 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.98 62.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.029 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.23 67.49 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.025 -0.422 . . . . 0.0 111.75 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.93 -24.09 66.04 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.257 -0.902 . . . . 0.0 111.073 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.38 -58.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 109.591 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.703 -1.141 . . . . 0.0 110.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -80.76 138.15 36.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.845 -0.535 . . . . 0.0 110.078 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.72 -91.2 0.19 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -121.82 137.58 27.42 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.901 -0.764 . . . . 0.0 110.03 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.16 100.45 0.99 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.304 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -93.33 -32.57 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -22.06 62.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.768 -0.582 . . . . 0.0 111.63 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.35 -37.19 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.646 -0.659 . . . . 0.0 109.887 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -75.64 -29.65 59.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.664 -0.648 . . . . 0.0 109.521 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.39 -42.22 96.25 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.02 -43.45 65.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.18 95.69 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 tp -67.3 -38.31 84.78 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 185' ' ' ILE . 5.7 tt -61.76 -37.13 83.16 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.723 -0.61 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.2 t -66.58 -33.78 76.44 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.206 -0.934 . . . . 0.0 109.642 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.95 -33.68 68.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.155 -0.341 . . . . 0.0 110.8 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.582 HG12 ' HA ' ' A' ' 182' ' ' LEU . 12.9 pt -82.34 -23.53 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.536 -0.727 . . . . 0.0 111.574 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.1 m -77.81 -28.15 50.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.413 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 38.6 t -59.41 -55.43 46.14 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.175 -0.953 . . . . 0.0 110.712 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 43.8 Cg_endo -66.21 -27.85 48.38 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.14 1.074 . . . . 0.0 111.257 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.16 -34.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.297 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 38.9 m -72.01 -39.1 69.43 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.451 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.0 -26.63 68.37 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.968 -0.457 . . . . 0.0 110.326 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -79.91 -37.47 34.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -38.14 73.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.977 -0.452 . . . . 0.0 110.438 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 191' ' ' ALA . 27.4 m -73.63 -9.42 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.58 -0.7 . . . . 0.0 111.858 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 mttp . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.16 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mttt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -78.54 134.08 37.3 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.636 -0.665 . . . . 0.0 110.332 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -97.22 71.12 0.74 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -121.37 118.45 29.91 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.759 -0.847 . . . . 0.0 110.643 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -80.99 63.35 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.756 1.398 . . . . 0.0 110.658 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -108.13 -12.57 15.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.21 -0.931 . . . . 0.0 111.907 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.6 m -65.14 -43.77 90.79 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.452 -0.78 . . . . 0.0 109.896 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.51 -34.02 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.61 -37.91 70.87 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -41.3 77.3 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.93 -46.75 77.07 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.55 98.44 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.38 -39.07 91.79 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.446 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 8.1 tp -61.73 -35.09 77.07 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.685 -0.634 . . . . 0.0 109.972 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.4 t -71.22 -33.48 69.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.473 -0.767 . . . . 0.0 109.567 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 64.2 m -76.04 -36.41 59.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.92 -0.487 . . . . 0.0 110.324 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.446 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -81.13 -21.77 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.573 -0.704 . . . . 0.0 111.916 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -80.05 -19.74 46.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.325 -0.86 . . . . 0.0 111.378 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.445 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 73.0 t -60.42 -53.84 60.76 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.12 -0.987 . . . . 0.0 110.77 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 44.2 Cg_endo -66.55 -30.09 43.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.074 1.039 . . . . 0.0 111.093 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.21 -43.9 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.2 m -64.1 -38.9 92.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' HG23 ' A' ' 194' ' ' VAL . . . -64.66 -33.54 76.19 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.035 0.445 . . . . 0.0 110.552 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.53 75.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -75.49 -34.15 60.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.008 -0.433 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.567 HG23 ' HA ' ' A' ' 191' ' ' ALA . 35.9 m -78.23 -9.11 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.381 -0.824 . . . . 0.0 111.785 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.353 -0.842 . . . . 0.0 109.78 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.424 0.631 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -149.25 166.8 27.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.785 -0.572 . . . . 0.0 110.447 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.01 -155.1 13.4 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -96.51 112.89 61.48 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.583 -0.951 . . . . 0.0 110.25 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.96 61.47 6.71 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.738 1.388 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.17 -14.76 15.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.918 . . . . 0.0 111.794 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.0 m -60.34 -35.47 75.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.639 -0.663 . . . . 0.0 110.433 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.41 -35.76 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -76.9 -33.93 57.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.58 -47.49 66.65 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -44.71 84.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.12 89.18 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.94 -47.68 73.87 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.525 HD12 HD12 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -54.77 -23.04 16.12 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.972 -0.455 . . . . 0.0 111.139 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 t -82.95 -21.28 34.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.769 -1.207 . . . . 0.0 109.214 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 63.5 m -96.63 -30.89 13.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.79 -0.569 . . . . 0.0 111.337 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 182' ' ' LEU . 0.0 OUTLIER -71.35 -17.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 121.121 -0.987 . . . . 0.0 111.278 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.414 HG23 HD13 ' A' ' 185' ' ' ILE . 0.7 OUTLIER -71.37 -23.53 61.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.811 -0.556 . . . . 0.0 111.597 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.542 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 54.6 t -75.17 -55.3 2.27 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.134 -0.979 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -73.69 -7.31 19.99 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 O-C-N 123.167 1.088 . . . . 0.0 113.119 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.603 1.092 . . . . 0.0 110.381 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.2 m -66.63 -40.41 88.73 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.448 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.39 -34.67 78.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.2 88.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -71.13 -37.16 72.32 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.988 -0.445 . . . . 0.0 110.205 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.448 HG22 ' HA ' ' A' ' 191' ' ' ALA . 34.7 m -85.0 -2.17 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.409 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.046 0.45 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -112.84 152.06 29.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.605 -0.684 . . . . 0.0 110.202 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.98 -38.72 1.58 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.134 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -76.18 134.95 70.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 118.38 1.09 . . . . 0.0 111.557 -179.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -85.22 86.33 1.11 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.573 1.302 . . . . 0.0 110.19 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -89.87 -30.41 17.92 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.462 -0.774 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 67.3 m -60.62 -25.28 66.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.92 -0.488 . . . . 0.0 111.498 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.1 tt -60.28 -40.76 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.868 -0.52 . . . . 0.0 110.514 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -81.72 -29.47 32.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.541 -0.724 . . . . 0.0 109.152 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.96 -44.88 72.06 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.435 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.65 -42.22 71.1 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.72 94.56 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.417 ' O ' HG12 ' A' ' 185' ' ' ILE . 7.7 tp -70.1 -40.26 75.03 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.43 -39.34 76.03 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 122.099 -0.376 . . . . 0.0 110.18 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.2 t -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.5 t -67.36 -37.44 83.22 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 181' ' ' LEU . 17.3 mm -65.89 -36.05 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.659 -0.651 . . . . 0.0 110.359 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.5 m -76.44 -20.36 57.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.999 -0.438 . . . . 0.0 111.454 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 38.9 t -55.13 -56.83 23.89 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -67.28 -25.61 42.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.033 1.017 . . . . 0.0 111.033 179.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.9 t -66.21 -47.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 15.4 m -63.46 -36.96 85.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 120.894 0.378 . . . . 0.0 110.152 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.63 91.93 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.67 -33.9 73.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -69.74 -29.69 67.12 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 110.669 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.8 t -78.12 -34.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 109.571 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.719 -179.775 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.237 0.542 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -127.32 143.26 51.26 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.605 -0.684 . . . . 0.0 110.123 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.93 -115.74 1.01 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.59 134.8 24.7 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.825 -0.809 . . . . 0.0 110.682 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.88 69.72 7.82 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.89 1.468 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -105.34 -11.78 16.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.48 -0.763 . . . . 0.0 111.318 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.5 m -61.76 -37.27 83.66 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.26 -31.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -68.08 -39.83 82.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.88 -39.41 76.3 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -44.7 86.24 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.03 97.65 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -42.19 98.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.493 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.8 tt -61.99 -36.21 80.82 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.949 -0.469 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 t -65.89 -31.03 71.74 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.291 -0.881 . . . . 0.0 109.842 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.4 t -77.74 -36.98 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.94 -0.475 . . . . 0.0 110.075 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.493 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.5 pt -84.6 -18.74 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.56 -0.713 . . . . 0.0 112.164 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.8 t -78.41 -21.69 48.89 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 54.4 t -60.54 -53.65 62.44 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.117 -0.989 . . . . 0.0 110.731 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 44.9 Cg_endo -67.29 -31.02 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.03 1.016 . . . . 0.0 110.837 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.23 -40.92 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.3 m -66.46 -38.64 87.77 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -63.27 -34.7 78.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 120.999 0.428 . . . . 0.0 109.998 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.3 73.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -37.5 66.18 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.925 -0.484 . . . . 0.0 110.408 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -79.14 -1.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.579 -0.701 . . . . 0.0 111.964 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 tttp . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.219 179.838 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -83.45 144.9 29.28 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.852 -0.53 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.12 152.1 24.06 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -88.99 134.57 33.16 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.494 -1.003 . . . . 0.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.44 62.36 7.65 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.854 1.45 . . . . 0.0 110.825 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.66 -59.4 1.88 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.1 t -64.59 -26.31 68.35 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.092 -0.38 . . . . 0.0 110.627 179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.0 mm -63.51 -43.52 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.43 -34.04 69.94 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 16.8 mt -66.65 -44.95 80.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.302 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.41 -44.85 70.55 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.72 89.67 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' O ' HG12 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -69.92 -45.65 67.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.997 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 -33.47 47.89 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.094 -0.379 . . . . 0.0 111.128 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.9 t -57.99 -27.7 63.71 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.779 -0.576 . . . . 0.0 110.584 179.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . 0.408 ' HA ' ' CG ' ' A' ' 188' ' ' PRO . 85.1 m -95.57 -7.41 37.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.03 -0.419 . . . . 0.0 111.458 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 181' ' ' LEU . 18.6 mm -104.88 -6.85 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.924 -1.11 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 61.5 m -110.17 -47.88 3.25 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.1 -1.0 . . . . 0.0 113.196 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.424 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 59.6 t -90.0 -55.37 0.29 Allowed Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.424 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.4 Cg_endo -67.05 -0.82 5.21 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 N-CA-C 114.827 1.049 . . . . 0.0 114.827 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.25 -33.62 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-N 119.382 0.992 . . . . 0.0 111.369 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -60.85 -43.67 98.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.869 -0.519 . . . . 0.0 109.739 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.56 ' HA ' HG21 ' A' ' 194' ' ' VAL . . . -67.6 -33.47 75.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.74 78.78 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 109.629 179.34 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -74.98 -35.2 62.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.886 -0.509 . . . . 0.0 111.094 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.56 HG21 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -79.93 -4.53 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.407 -0.808 . . . . 0.0 112.055 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.356 179.75 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.775 0.322 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -155.88 149.08 24.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.751 -0.593 . . . . 0.0 110.594 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.03 -54.99 1.79 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.43 122.85 86.98 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.732 -0.864 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.26 -177.67 4.05 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.876 1.461 . . . . 0.0 111.19 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 11.3 3.63 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.4 m -95.44 -29.07 14.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 110.227 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.6 mm -58.85 -43.41 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -71.33 -33.31 69.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.737 -0.602 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.14 -43.96 66.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.0 -43.86 81.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.13 99.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.809 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.6 tt -68.15 -37.99 81.63 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -23.61 64.98 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.544 -0.723 . . . . 0.0 111.459 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.9 t -56.93 -33.95 67.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 119.143 0.883 . . . . 0.0 110.099 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 57.7 m -82.01 -23.3 36.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.864 -0.522 . . . . 0.0 110.26 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.9 mm -88.93 -8.24 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.34 -0.85 . . . . 0.0 112.021 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 m -52.63 -31.21 35.55 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.255 -0.903 . . . . 0.0 111.968 -179.808 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.529 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 74.4 t -81.88 -57.46 0.51 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.428 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.4 Cg_endo -69.69 -4.73 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 O-C-N 122.991 0.995 . . . . 0.0 113.768 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 9.3 p -59.68 -38.48 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-N 119.634 1.107 . . . . 0.0 111.106 -179.953 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.0 m -70.07 -36.78 75.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 109.607 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . 0.442 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -67.6 -27.78 67.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 120.776 0.322 . . . . 0.0 110.549 179.406 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.23 62.52 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -37.24 66.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.968 -0.457 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -77.11 -2.05 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.247 -0.908 . . . . 0.0 111.759 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.5 tttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.571 179.836 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.2 tttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 132.6 45.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.594 -0.691 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -100.56 -137.6 9.87 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.35 96.67 40.49 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.618 -0.931 . . . . 0.0 110.062 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.47 72.21 5.09 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.622 1.327 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -102.87 -30.53 10.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.668 -0.645 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.0 p -62.73 -33.27 74.77 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.872 -0.518 . . . . 0.0 110.635 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 mm -63.99 -39.32 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.83 -32.06 68.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.45 -44.13 83.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.03 -43.1 68.6 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.84 96.89 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' O ' HG12 ' A' ' 185' ' ' ILE . 3.2 tt -66.96 -43.82 82.1 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.941 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -36.0 79.28 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.95 -0.469 . . . . 0.0 109.841 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.0 t -59.62 -38.95 82.68 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.26 -22.31 62.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.901 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.402 HG12 ' O ' ' A' ' 181' ' ' LEU . 31.0 mm -86.4 -32.29 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.1 m -77.95 -24.31 48.23 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.025 -0.422 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.419 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 12.1 t -58.53 -53.95 60.96 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.195 -0.941 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 46.6 Cg_endo -68.16 -15.45 42.86 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.201 1.106 . . . . 0.0 112.806 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.34 -43.21 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.363 -0.836 . . . . 0.0 109.675 179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.8 m -67.43 -33.46 75.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.731 -0.606 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -72.89 -13.75 61.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.953 -0.467 . . . . 0.0 111.46 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.26 -20.64 63.04 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.458 -0.776 . . . . 0.0 111.927 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.19 -23.55 64.08 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.176 -0.953 . . . . 0.0 111.904 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.8 p -50.84 -38.15 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.601 -0.687 . . . . 0.0 111.782 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.401 ' HB3' ' HE3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.559 -0.734 . . . . 0.0 109.248 179.647 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 120.761 0.315 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -109.9 124.99 52.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.551 -0.718 . . . . 0.0 110.097 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.43 -101.21 0.14 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -68.04 134.8 91.7 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.823 -0.81 . . . . 0.0 110.98 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -77.8 9.2 3.06 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 O-C-N 123.695 1.366 . . . . 0.0 112.496 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -108.06 -19.24 13.56 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.061 -1.024 . . . . 0.0 111.175 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.411 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -60.34 -33.57 72.6 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.573 -0.704 . . . . 0.0 110.626 179.763 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 177' ' ' PHE . 30.2 pt -61.33 -37.61 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' PHE . . . . . 0.417 ' N ' HG13 ' A' ' 176' ' ' ILE . 0.5 OUTLIER -79.5 -33.41 42.16 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.951 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 11.7 mt -67.42 -43.82 80.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.83 -46.27 69.01 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.84 88.81 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.205 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.42 -32.31 58.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.987 -0.445 . . . . 0.0 109.926 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.1 OUTLIER -57.47 -40.8 79.33 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.832 -0.542 . . . . 0.0 110.832 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -62.18 -35.84 80.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.544 -0.722 . . . . 0.0 109.515 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -76.04 -31.98 59.11 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.2 -0.312 . . . . 0.0 110.931 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.534 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 4.6 pt -90.52 -1.6 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 35.2 m -46.46 -45.02 17.93 Favored 'General case' 0 N--CA 1.512 2.631 0 CA-C-N 119.448 1.022 . . . . 0.0 112.024 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.445 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 40.3 t -76.23 -55.93 1.66 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.39 -0.819 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.519 ' HG2' ' HA ' ' A' ' 185' ' ' ILE . 49.2 Cg_endo -69.86 -1.46 8.59 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.059 1.173 . . . . 0.0 114.109 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.89 -40.64 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-N 119.668 1.122 . . . . 0.0 112.046 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -70.08 -34.6 73.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.071 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.92 -24.66 61.67 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.097 -0.377 . . . . 0.0 110.522 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.48 -39.36 22.59 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.897 -0.502 . . . . 0.0 110.145 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.632 -0.668 . . . . 0.0 110.705 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 7.4 p -77.05 -25.52 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.757 . . . . 0.0 111.189 179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.087 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.98 0.419 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.89 103.39 11.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.679 -0.638 . . . . 0.0 110.248 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.23 -121.42 1.96 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -121.84 134.22 24.59 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.865 . . . . 0.0 110.322 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.96 70.62 5.4 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.777 1.409 . . . . 0.0 110.954 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -94.13 -33.02 13.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 39.0 m -57.11 -28.4 62.63 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.037 -0.415 . . . . 0.0 111.037 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.96 -42.52 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.63 -33.82 69.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.94 -47.17 72.49 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.81 -43.03 84.89 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.42 96.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 181' ' ' LEU . 3.3 tm? -65.64 -41.48 92.56 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 185' ' ' ILE . 9.1 tp -59.74 -37.52 79.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.898 -0.502 . . . . 0.0 109.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 187' ' ' VAL . 15.8 t -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 29.0 m -72.87 -41.59 64.57 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 182' ' ' LEU . 2.0 pt -80.07 -8.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.725 -0.609 . . . . 0.0 112.33 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.715 ' O ' HG22 ' A' ' 189' ' ' VAL . 2.7 t -102.23 2.93 37.74 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.989 . . . . 0.0 111.787 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 183' ' ' SER . 63.8 t -73.37 -50.93 5.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 120.54 -1.35 . . . . 0.0 111.083 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.3 Cg_endo -75.3 -7.45 18.9 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.022 1.011 . . . . 0.0 113.259 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 186' ' ' THR . 11.3 m -64.32 -31.46 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.053 -1.029 . . . . 0.0 110.795 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m -64.4 -44.11 92.31 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.18 -28.75 69.61 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.171 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.33 66.11 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.785 -0.572 . . . . 0.0 109.772 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.08 -32.89 44.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.641 . . . . 0.0 110.974 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 191' ' ' ALA . 36.0 m -78.74 -11.05 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.415 -0.803 . . . . 0.0 112.097 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.002 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.491 0.662 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.3 OUTLIER -155.74 155.2 32.69 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.595 -0.691 . . . . 0.0 110.437 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.28 116.34 4.8 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 75.7 m-85 -110.44 110.33 57.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.644 -0.916 . . . . 0.0 110.754 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.98 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.404 1.213 . . . . 0.0 110.359 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -95.76 -28.3 14.83 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.7 m -66.25 -19.6 65.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.096 -0.377 . . . . 0.0 110.903 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.53 -39.6 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 118.934 0.788 . . . . 0.0 109.558 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -75.97 -33.16 59.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -67.47 -47.18 70.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.37 -43.69 85.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.69 95.16 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.53 -39.08 81.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.569 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.8 OUTLIER -59.35 -37.97 79.21 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.858 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.4 t -61.27 -36.18 79.32 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.478 -0.764 . . . . 0.0 110.164 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.2 m -75.11 -35.06 61.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.183 -0.323 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 10.7 pt -89.25 -4.71 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.549 -0.72 . . . . 0.0 112.772 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 m -48.51 -41.2 29.31 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.245 -0.909 . . . . 0.0 112.144 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.539 ' HB ' ' CD ' ' A' ' 188' ' ' PRO . 83.9 t -61.87 -62.01 6.67 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.482 -0.761 . . . . 0.0 110.512 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.539 ' CD ' ' HB ' ' A' ' 187' ' ' VAL . 43.6 Cg_endo -64.26 -24.36 65.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 122.938 0.967 . . . . 0.0 111.824 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 185' ' ' ILE . 7.0 t -63.66 -51.66 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.7 m -66.46 -31.94 73.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.115 -0.365 . . . . 0.0 110.472 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -74.55 -34.38 62.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.932 -0.48 . . . . 0.0 110.328 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.99 62.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.188 -0.32 . . . . 0.0 110.727 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.74 34.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.293 -0.88 . . . . 0.0 110.505 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.13 -41.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.836 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.15 159.11 35.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.787 -0.57 . . . . 0.0 110.634 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -106.0 58.86 0.43 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.21 120.86 28.9 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 122.061 -0.67 . . . . 0.0 110.299 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.37 -171.39 1.15 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 124.002 1.527 . . . . 0.0 111.244 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.0 t80 69.18 0.27 2.77 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.035 -0.415 . . . . 0.0 111.837 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -42.87 66.49 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.5 tt -64.32 -33.22 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -68.41 -36.36 78.99 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -65.28 -41.26 94.35 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.42 -45.91 61.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.86 86.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 185' ' ' ILE . 4.2 tp -72.3 -37.04 69.07 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -50.87 -43.08 59.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.97 -0.456 . . . . 0.0 110.841 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 187' ' ' VAL . 7.2 t -62.53 -30.03 71.0 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.757 -0.59 . . . . 0.0 110.465 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 83.4 m -76.76 -34.56 58.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 181' ' ' LEU . 19.7 mm -70.16 -33.92 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.766 -0.584 . . . . 0.0 110.456 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.2 p -69.99 -23.17 63.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.731 -0.606 . . . . 0.0 111.826 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.516 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 99.4 t -61.13 -57.23 27.54 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 121.284 -0.885 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 44.3 Cg_endo -65.99 -28.44 49.73 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.067 1.035 . . . . 0.0 110.947 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' ILE . 53.1 t -63.45 -43.39 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.2 m -62.73 -37.97 88.66 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.062 0.458 . . . . 0.0 109.766 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.04 -29.08 70.25 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.51 -35.61 27.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 110.451 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -38.61 53.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.635 -0.666 . . . . 0.0 111.462 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.91 -35.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.399 -0.813 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.728 179.69 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.857 0.36 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -100.72 18.25 19.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.455 -0.778 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.37 -95.99 0.32 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -121.02 77.38 31.44 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.985 -0.715 . . . . 0.0 109.262 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.78 58.77 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.27 1.313 . . . . 0.0 111.735 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -100.13 -8.44 23.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.369 -0.832 . . . . 0.0 110.718 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 1.5 t -59.29 -30.67 68.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.8 pp -59.44 -40.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -34.03 60.35 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 27.8 mt -64.66 -41.15 96.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -44.84 68.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.96 97.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -71.73 -38.12 70.49 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.806 -0.559 . . . . 0.0 109.778 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.0 OUTLIER -62.41 -40.11 95.44 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.728 -0.608 . . . . 0.0 110.454 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.0 t -60.51 -36.67 78.93 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.767 -1.208 . . . . 0.0 110.077 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.03 -42.09 69.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.155 -0.341 . . . . 0.0 110.251 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -81.94 -18.11 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.627 -0.671 . . . . 0.0 112.095 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 85.3 m -86.3 -5.64 59.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.418 -0.801 . . . . 0.0 111.119 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 52.2 t -51.15 -51.41 68.32 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.728 -1.233 . . . . 0.0 111.636 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.2 Cg_endo -72.21 -3.51 13.45 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 O-C-N 123.19 1.1 . . . . 0.0 113.577 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -58.37 -29.19 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.106 -0.996 . . . . 0.0 111.23 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 194' ' ' VAL . 7.6 m -58.99 -44.56 91.64 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -65.55 -38.84 90.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.31 -34.93 69.23 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.75 -32.59 46.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.747 -0.596 . . . . 0.0 110.153 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 190' ' ' SER . 46.5 t -63.9 -40.37 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.449 -0.782 . . . . 0.0 109.46 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.088 0.471 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 173' ' ' PRO . 0.2 OUTLIER -91.95 122.97 34.96 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.275 -0.891 . . . . 0.0 110.502 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -87.52 -59.09 1.76 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.07 84.0 32.37 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.654 -0.91 . . . . 0.0 109.376 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 48.3 Cg_endo -75.86 -31.28 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.645 1.34 . . . . 0.0 111.912 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.15 -42.06 89.54 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.717 -0.614 . . . . 0.0 111.172 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.0 p -62.58 -27.92 69.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.017 -0.427 . . . . 0.0 111.344 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.39 -43.5 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -30.84 67.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 3.1 mm? -67.34 -45.88 75.1 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.39 -43.76 69.38 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.03 96.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 185' ' ' ILE . 1.3 tt -68.12 -40.66 82.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.87 -40.12 75.57 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.863 -0.523 . . . . 0.0 110.146 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 t -62.48 -37.19 85.02 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.6 m -68.83 -34.19 75.08 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 181' ' ' LEU . 14.9 mm -67.25 -33.56 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.642 -0.661 . . . . 0.0 109.555 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 m -67.59 -29.18 68.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.934 -0.479 . . . . 0.0 110.853 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 63.6 t -54.71 -59.08 11.46 Favored Pre-proline 0 N--CA 1.506 2.348 0 O-C-N 121.567 -0.708 . . . . 0.0 111.669 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 46.9 Cg_endo -67.75 -32.51 29.84 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 O-C-N 122.994 0.997 . . . . 0.0 111.29 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.85 -43.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 m -69.52 -31.24 69.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.108 -0.37 . . . . 0.0 110.286 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.13 68.13 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.761 -0.587 . . . . 0.0 110.209 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -87.32 -36.93 17.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.847 -0.533 . . . . 0.0 109.952 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.61 -40.83 98.17 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.635 -0.666 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.91 -34.39 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.724 -0.61 . . . . 0.0 110.481 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.148 179.859 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.903 0.382 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 175.49 7.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.786 -0.571 . . . . 0.0 110.71 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 147.65 -134.94 5.37 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.37 74.13 30.58 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.635 -0.92 . . . . 0.0 110.206 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.67 168.1 24.25 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.677 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.9 t80 63.13 7.96 3.04 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.9 p -84.79 -40.96 16.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.846 -1.159 . . . . 0.0 109.44 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.5 -34.12 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.84 -33.39 57.91 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.0 mt -62.7 -41.3 99.06 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mp -73.47 -45.38 54.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.19 84.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 185' ' ' ILE . 5.2 tt -76.79 -35.89 57.35 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.59 -40.01 71.48 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.814 -0.554 . . . . 0.0 111.106 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.36 73.98 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 3.6 t -76.16 -9.73 58.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.975 -0.453 . . . . 0.0 110.806 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 189' ' ' VAL . 38.0 mm -101.34 -38.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.165 -0.96 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.3 t -67.01 -32.27 73.38 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.016 -0.428 . . . . 0.0 111.464 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.502 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 49.4 t -67.09 -53.98 22.44 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.212 -0.93 . . . . 0.0 111.417 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -70.28 -2.9 11.3 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.102 1.201 . . . . 0.0 114.24 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 185' ' ' ILE . 23.5 t -56.23 -49.36 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 119.933 1.242 . . . . 0.0 110.76 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.4 m -60.17 -38.93 84.72 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.98 -0.45 . . . . 0.0 109.989 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -66.79 -37.42 84.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.38 73.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -25.5 46.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.795 -0.566 . . . . 0.0 110.984 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 191' ' ' ALA . 32.6 m -97.0 0.67 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.405 -0.81 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt . . . . . 0 N--CA 1.505 2.281 0 O-C-N 121.418 -0.801 . . . . 0.0 111.896 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -105.09 144.05 32.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.895 -0.503 . . . . 0.0 110.128 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.04 65.49 3.96 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -121.77 88.48 47.22 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.931 -0.746 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.24 -7.28 19.56 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.631 1.332 . . . . 0.0 112.38 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.28 18.4 15.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.326 -0.858 . . . . 0.0 111.133 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 p -89.22 -24.44 22.13 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.018 -1.051 . . . . 0.0 110.77 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.5 -46.82 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -72.9 -33.04 65.75 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 13.8 tp -65.8 -46.43 78.72 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.9 tp -69.27 -43.44 73.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.43 92.54 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tp -74.98 -33.99 61.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -60.32 -38.38 83.53 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.667 -0.646 . . . . 0.0 110.12 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.1 t -57.36 -39.0 75.05 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.439 0.638 . . . . 0.0 109.768 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.11 -13.97 62.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.714 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 38.0 mm -97.53 -33.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.096 -1.002 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.8 m -73.26 -35.78 66.25 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.049 -0.407 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.542 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 42.7 t -59.62 -53.73 62.85 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.8 Cg_endo -72.9 -3.42 13.56 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.154 1.081 . . . . 0.0 113.222 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.2 p -56.99 -30.14 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.102 -0.999 . . . . 0.0 111.444 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 194' ' ' VAL . 11.7 m -61.28 -43.15 99.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.655 -0.653 . . . . 0.0 109.414 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.74 70.65 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.53 69.6 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -82.65 -32.72 28.08 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.583 -0.698 . . . . 0.0 109.716 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 190' ' ' SER . 58.1 t -78.49 -52.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.638 -0.664 . . . . 0.0 109.213 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' HD3' HG12 ' A' ' 194' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.798 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.46 34.68 3.92 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.586 -0.697 . . . . 0.0 111.072 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.88 176.88 30.8 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -120.84 80.63 33.27 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.658 -0.907 . . . . 0.0 109.673 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.48 179.87 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.494 1.26 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.641 ' O ' HD13 ' A' ' 178' ' ' LEU . 0.2 OUTLIER 61.78 8.74 2.54 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 58.9 m -97.37 -30.07 13.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.226 -0.921 . . . . 0.0 110.464 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -61.72 -42.05 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.28 -30.25 57.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.772 -0.58 . . . . 0.0 109.871 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 174' ' ' PHE . 3.7 mp -70.67 -44.59 66.73 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.41 -43.49 66.67 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.51 97.16 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.75 -36.56 75.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HA ' HD12 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -60.37 -39.11 86.04 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.715 -0.616 . . . . 0.0 109.766 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.2 t -61.12 -32.86 72.54 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.436 0.636 . . . . 0.0 109.523 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.72 -21.91 54.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.071 -0.393 . . . . 0.0 110.596 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 182' ' ' LEU . 37.4 mt -88.74 -31.43 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.183 -0.948 . . . . 0.0 110.46 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.9 p -73.9 -32.29 63.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.905 -0.497 . . . . 0.0 111.718 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.489 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 34.2 t -60.03 -53.94 60.29 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.177 -0.952 . . . . 0.0 111.477 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.5 Cg_endo -71.82 -4.59 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.025 1.013 . . . . 0.0 113.408 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.85 -31.2 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.947 -1.095 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 194' ' ' VAL . 47.5 m -67.51 -41.41 84.49 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -70.41 -29.89 66.62 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 120.851 0.358 . . . . 0.0 110.306 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -67.76 -32.7 73.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.876 -0.515 . . . . 0.0 110.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -92.04 -23.95 19.34 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.509 -0.744 . . . . 0.0 111.844 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -86.17 -1.47 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.03 -1.044 . . . . 0.0 111.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.177 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -161.97 -178.86 6.72 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.97 0.414 . . . . 0.0 110.484 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.48 -122.64 4.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -121.54 134.95 24.72 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.855 . . . . 0.0 110.361 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.37 72.02 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.758 1.399 . . . . 0.0 110.652 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -111.25 -23.64 10.72 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.278 -0.888 . . . . 0.0 111.811 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.8 m -60.18 -35.1 74.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 177' ' ' PHE . 44.8 pt -63.24 -36.64 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.409 ' N ' HG13 ' A' ' 176' ' ' ILE . 68.6 m-85 -73.44 -32.69 64.52 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 14.4 mt -63.43 -42.51 98.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.4 tp -72.24 -45.09 61.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.13 95.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tp -72.32 -33.49 67.4 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 185' ' ' ILE . 0.1 OUTLIER -54.35 -45.36 72.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.902 -0.499 . . . . 0.0 109.993 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.1 t -65.18 -34.44 78.38 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.15 -29.97 62.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.239 -0.288 . . . . 0.0 110.879 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 182' ' ' LEU . 3.1 pt -93.81 -8.38 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.534 -0.729 . . . . 0.0 112.11 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.2 m -70.63 -46.39 63.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.131 -0.98 . . . . 0.0 109.813 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 72.3 t -60.75 -52.08 75.07 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.414 -0.803 . . . . 0.0 110.905 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.2 Cg_endo -70.23 -3.31 12.07 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.009 1.139 . . . . 0.0 113.589 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.11 -26.96 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.064 -1.023 . . . . 0.0 111.322 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.3 m -64.66 -41.87 95.79 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.538 -0.726 . . . . 0.0 109.304 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.61 70.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.901 0.382 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.44 60.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.783 -0.573 . . . . 0.0 110.424 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -42.27 68.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.614 -0.679 . . . . 0.0 111.111 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.16 -35.49 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.233 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 158.64 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.504 -0.747 . . . . 0.0 110.307 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -66.19 -74.84 0.48 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.27 109.73 57.63 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.878 -0.778 . . . . 0.0 109.758 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.88 51.1 3.07 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.34 1.36 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -104.02 4.5 34.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.208 -0.933 . . . . 0.0 111.545 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 12.9 p -79.86 -23.83 41.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.305 -0.872 . . . . 0.0 110.981 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 mt -56.95 -48.57 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.824 -0.548 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.54 -30.16 61.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.713 -0.617 . . . . 0.0 109.635 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 14.4 mt -69.35 -42.83 74.73 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 179' ' ' LEU . 3.7 mm? -69.79 -43.0 73.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.26 90.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -66.62 -37.34 84.65 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.506 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 2.3 tt -61.05 -39.71 90.88 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.7 t -62.53 -35.59 79.89 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.254 -0.903 . . . . 0.0 109.781 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 46.5 m -75.94 -32.74 59.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.132 -0.355 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.506 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -93.38 -8.07 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.442 -0.786 . . . . 0.0 112.315 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.4 m -84.62 -41.8 16.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.168 -0.958 . . . . 0.0 110.323 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.613 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 35.7 m -63.74 -36.61 22.59 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.034 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.613 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.9 Cg_endo -73.65 -11.3 24.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 CA-C-N 119.872 0.99 . . . . 0.0 112.236 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -29.14 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.291 -0.88 . . . . 0.0 111.12 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 194' ' ' VAL . 71.1 m -60.52 -40.99 93.5 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.206 0.527 . . . . 0.0 109.764 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -66.87 -30.41 70.57 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.02 -28.06 64.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.874 -0.516 . . . . 0.0 110.207 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -89.78 -33.13 16.65 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.416 -0.803 . . . . 0.0 110.495 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.5 m -79.63 -1.86 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.401 -0.812 . . . . 0.0 112.123 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.474 179.809 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.382 0.611 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -153.66 175.94 12.67 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.488 -0.757 . . . . 0.0 110.5 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.25 144.34 13.78 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -121.75 134.72 24.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.887 . . . . 0.0 109.888 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.13 51.74 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.63 1.331 . . . . 0.0 112.119 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -103.86 -34.55 8.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.964 -1.085 . . . . 0.0 110.226 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.2 m -60.55 -30.05 69.53 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.899 -0.501 . . . . 0.0 110.659 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 tp -58.61 -39.01 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 122.068 -0.395 . . . . 0.0 110.173 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -78.28 -32.05 49.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.529 -0.732 . . . . 0.0 109.099 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.25 -45.19 73.87 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -41.12 73.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.61 -45.13 95.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.82 -34.78 69.6 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.36 -39.4 90.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.645 -0.659 . . . . 0.0 110.073 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -57.87 -38.74 76.27 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.711 -0.618 . . . . 0.0 109.706 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.71 -25.66 68.04 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.172 -0.33 . . . . 0.0 110.62 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 37.5 mm -86.41 -40.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.521 -0.737 . . . . 0.0 110.175 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 56.9 m -73.64 -32.55 64.08 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.008 -0.433 . . . . 0.0 111.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.414 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 5.5 t -53.08 -55.97 28.51 Favored Pre-proline 0 N--CA 1.507 2.411 0 CA-C-N 119.429 1.013 . . . . 0.0 111.17 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 45.6 Cg_endo -67.08 -31.4 36.84 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.26 1.137 . . . . 0.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -43.4 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.5 m -61.11 -40.68 94.69 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -64.67 -32.34 73.96 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.144 -0.347 . . . . 0.0 110.212 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.91 68.58 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -36.23 65.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.933 -0.48 . . . . 0.0 110.682 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 191' ' ' ALA . 31.1 m -76.3 -10.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.16 -0.962 . . . . 0.0 111.749 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.477 -0.764 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 42.2 mttt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 132.83 51.88 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.554 -0.717 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.66 -174.3 30.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -91.53 134.86 28.65 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.686 -0.89 . . . . 0.0 109.966 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.86 176.24 9.26 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.722 1.38 . . . . 0.0 111.493 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.14 13.64 5.95 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.106 -0.371 . . . . 0.0 111.815 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.9 p -96.86 -30.75 12.96 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.411 -0.806 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tp -55.25 -38.12 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 122.199 -0.313 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -74.59 -33.41 62.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.57 -0.706 . . . . 0.0 109.55 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -45.07 68.56 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.436 ' HA ' HD13 ' A' ' 179' ' ' LEU . 3.9 mm? -67.48 -43.73 80.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.2 97.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.14 -40.11 90.37 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 185' ' ' ILE . 0.1 OUTLIER -60.59 -38.15 83.69 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.701 -0.624 . . . . 0.0 109.817 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.7 t -62.83 -37.35 86.44 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -67.91 -13.7 62.37 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.154 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 182' ' ' LEU . 62.7 mt -97.18 -39.67 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 189' ' ' VAL . 30.0 m -72.87 -33.35 66.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.083 -0.386 . . . . 0.0 111.795 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 41.8 t -61.58 -53.72 58.78 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.86 -1.15 . . . . 0.0 111.468 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -72.62 -8.8 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.062 1.033 . . . . 0.0 113.333 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER -65.06 -28.97 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.076 -1.015 . . . . 0.0 111.186 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 m -63.44 -38.9 92.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.732 -0.605 . . . . 0.0 109.937 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.84 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.66 70.83 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.228 -0.295 . . . . 0.0 110.438 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -85.99 -21.78 27.65 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.305 -0.872 . . . . 0.0 110.473 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.6 t -90.49 -53.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.365 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 156.99 40.05 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.694 -0.629 . . . . 0.0 109.675 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 178.1 -63.66 0.08 OUTLIER Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.964 -1.113 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.78 133.6 69.85 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.597 -0.943 . . . . 0.0 111.131 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HB2' HD12 ' A' ' 176' ' ' ILE . 50.7 Cg_endo -84.31 72.06 5.24 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.509 1.473 . . . . 0.0 110.608 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -100.29 -16.9 17.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.432 -0.792 . . . . 0.0 112.282 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.559 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 46.3 m -73.5 -21.4 60.42 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.255 -0.903 . . . . 0.0 112.114 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' PRO . 34.6 mt -58.39 -47.74 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.776 -0.578 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -78.56 -27.28 45.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 13.2 mt -68.6 -47.28 67.12 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -42.91 86.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.16 -47.73 84.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.7 tp -68.14 -35.15 77.63 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.647 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.733 HD13 HD11 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.639 -0.663 . . . . 0.0 109.985 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 186' ' ' THR . 8.7 t -66.5 -35.14 79.51 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.367 -0.833 . . . . 0.0 109.817 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 7.7 t -74.34 -41.67 60.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.985 -0.447 . . . . 0.0 109.985 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.733 HD11 HD13 ' A' ' 182' ' ' LEU . 2.3 pp -79.1 -20.49 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.535 -0.728 . . . . 0.0 112.131 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 183' ' ' SER . 2.8 t -77.4 -17.71 57.92 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.15 -0.969 . . . . 0.0 111.878 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.514 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 86.9 t -59.72 -54.79 52.25 Favored Pre-proline 0 N--CA 1.505 2.32 0 O-C-N 121.066 -1.021 . . . . 0.0 110.75 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -67.55 -29.37 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.111 1.058 . . . . 0.0 110.977 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.59 -43.36 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.8 m -62.8 -39.16 93.41 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.056 0.455 . . . . 0.0 109.775 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.44 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -67.05 -24.27 65.96 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.119 -0.363 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -78.35 -38.2 42.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 109.476 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -74.14 -35.67 64.09 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.522 -0.736 . . . . 0.0 110.562 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -73.39 -9.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.458 -0.776 . . . . 0.0 111.59 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.033 179.782 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.96 74.98 1.54 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.549 -0.719 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.83 59.87 6.18 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.01 131.79 55.75 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.437 -1.037 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -82.65 78.04 3.49 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.898 1.473 . . . . 0.0 111.063 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -78.06 -35.77 49.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -0.81 . . . . 0.0 110.48 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -31.39 65.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.977 -0.452 . . . . 0.0 110.935 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 mm -60.77 -43.12 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.89 -31.32 67.93 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -42.56 90.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.572 -0.705 . . . . 0.0 109.555 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.78 -44.69 69.6 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.8 98.32 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD13 ' C ' ' A' ' 181' ' ' LEU . 3.2 tm? -67.07 -43.06 83.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tt -58.28 -37.78 75.69 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.956 -0.465 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 187' ' ' VAL . 33.7 t -63.19 -39.23 94.04 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.2 m -67.57 -13.38 62.01 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 181' ' ' LEU . 43.1 mm -98.12 -35.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.1 m -76.47 -37.68 56.53 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.628 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.6 m -68.25 -38.96 14.61 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.816 -1.178 . . . . 0.0 113.478 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.628 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.4 Cg_endo -71.55 -38.12 4.79 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 119.798 0.963 . . . . 0.0 111.485 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 -33.41 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.141 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 m -69.85 -40.01 76.06 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 195' ' ' LYS . . . -65.71 -46.29 79.52 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.59 65.35 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 120.681 0.277 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.82 56.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.36 -54.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.516 -0.74 . . . . 0.0 109.58 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.57 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.097 0.475 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttm 51.23 59.19 4.78 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.589 -0.695 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.51 146.52 5.41 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -81.77 135.27 49.14 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.853 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.18 67.94 7.52 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.723 1.381 . . . . 0.0 111.065 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.47 -21.17 61.26 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.322 -0.861 . . . . 0.0 111.126 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -61.78 -18.99 61.96 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.8 mm -58.35 -49.29 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -80.05 -28.79 39.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.886 -0.509 . . . . 0.0 109.669 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 3.5 mm? -67.77 -43.44 79.8 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.45 -41.33 72.95 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.22 95.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -37.34 70.14 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 185' ' ' ILE . 25.1 tp -60.41 -36.95 79.32 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -37.43 81.62 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.2 -16.22 62.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.035 -0.416 . . . . 0.0 110.561 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 182' ' ' LEU . 57.3 mt -95.07 -36.0 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 110.385 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 189' ' ' VAL . 5.8 t -75.14 -19.16 60.03 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.688 -0.632 . . . . 0.0 112.537 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 24.2 t -75.28 -55.09 2.28 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 120.924 -1.11 . . . . 0.0 110.82 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -68.08 -28.8 34.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 122.963 0.98 . . . . 0.0 112.699 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 186' ' ' THR . 2.8 p -63.85 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.624 -0.673 . . . . 0.0 110.679 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.8 m -64.36 -43.52 94.28 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -72.08 -32.63 67.22 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.32 71.95 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.772 -0.58 . . . . 0.0 109.962 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -75.95 -37.3 58.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.786 -0.571 . . . . 0.0 109.633 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -91.79 1.73 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.506 2.355 0 O-C-N 121.39 -0.819 . . . . 0.0 112.145 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.413 0.625 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -160.88 130.68 4.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.53 50.34 55.42 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -105.66 134.38 19.74 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.767 -0.843 . . . . 0.0 109.894 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.91 63.68 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.913 1.48 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -116.38 -20.0 9.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.27 -0.894 . . . . 0.0 111.85 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 178' ' ' LEU . 23.3 m -58.78 -34.35 71.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.668 -0.645 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 mt -64.17 -41.12 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.44 -32.09 66.01 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 175' ' ' SER . 27.9 mt -62.76 -44.82 95.2 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -44.65 71.38 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.58 94.63 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.19 -34.01 65.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.877 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.11 -41.84 93.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -61.93 -34.67 76.52 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.231 -0.918 . . . . 0.0 109.678 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 43.8 m -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.244 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -96.85 -17.64 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.286 -0.883 . . . . 0.0 112.152 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.7 m -74.45 -40.43 61.91 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.365 -0.834 . . . . 0.0 109.96 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.521 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 69.2 t -59.63 -52.46 73.81 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.495 -0.753 . . . . 0.0 111.164 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.8 Cg_endo -71.09 -3.27 12.54 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 120.977 1.118 . . . . 0.0 113.731 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.73 -28.86 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 119.715 1.143 . . . . 0.0 111.173 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.2 m -61.4 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.505 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -84.56 -13.37 51.97 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -77.89 -44.93 25.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.447 -0.783 . . . . 0.0 110.32 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.85 -32.88 71.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.536 -0.728 . . . . 0.0 110.862 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.3 m -81.28 -2.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.557 -0.715 . . . . 0.0 111.845 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.8 -1.095 . . . . 0.0 109.988 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.864 0.364 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -95.74 128.67 42.82 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.25 70.73 0.33 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -121.02 127.78 26.05 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.973 -0.722 . . . . 0.0 109.972 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.17 177.09 9.08 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.864 1.455 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 178' ' ' LEU . 2.6 t80 63.59 9.43 4.27 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.957 -0.464 . . . . 0.0 112.085 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 1.7 t -92.23 -27.4 17.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.818 -1.176 . . . . 0.0 109.901 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.42 -41.01 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -75.76 -30.36 59.15 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 174' ' ' PHE . 2.4 mm? -67.0 -44.88 79.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.33 -42.59 75.12 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.93 92.66 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.35 -38.49 91.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.721 HD13 HD11 ' A' ' 185' ' ' ILE . 0.3 OUTLIER -58.76 -38.82 79.29 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -67.73 -34.94 77.84 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.573 -0.705 . . . . 0.0 109.724 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.1 t -75.12 -34.05 61.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.927 -0.483 . . . . 0.0 110.336 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.721 HD11 HD13 ' A' ' 182' ' ' LEU . 2.6 pp -89.2 -7.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.524 -0.735 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.581 ' O ' HG12 ' A' ' 189' ' ' VAL . 5.1 t -95.68 -24.91 16.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 111.456 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.575 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.2 m -73.25 -32.71 1.73 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 120.964 -1.085 . . . . 0.0 112.706 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.575 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 119.677 0.921 . . . . 0.0 111.629 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 186' ' ' THR . 0.9 OUTLIER -62.52 -29.83 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.853 -0.529 . . . . 0.0 110.583 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 m -67.69 -36.27 80.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.641 -0.662 . . . . 0.0 109.266 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -74.36 -13.5 60.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.139 -0.35 . . . . 0.0 111.343 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.38 -45.65 62.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.339 -0.851 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -72.4 -30.0 64.25 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.712 -0.618 . . . . 0.0 111.602 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.1 m -81.4 -1.22 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.282 -0.886 . . . . 0.0 112.155 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.316 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.836 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -80.48 79.84 7.02 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.519 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.39 -70.84 0.11 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -121.5 83.62 41.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.85 -0.794 . . . . 0.0 110.064 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.48 -172.75 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.726 1.382 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.11 13.54 4.78 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.08 -31.9 12.25 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -0.908 . . . . 0.0 110.314 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.7 -38.36 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 122.079 -0.388 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.83 -33.87 64.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.9 -41.54 97.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.84 -44.39 85.69 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.86 97.87 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -63.61 -40.44 96.93 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 185' ' ' ILE . 1.4 mp -64.1 -30.5 71.56 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 122.142 -0.348 . . . . 0.0 111.414 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -74.01 -33.92 63.96 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.983 -1.073 . . . . 0.0 109.209 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.37 -43.22 61.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.135 -0.353 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.3 pp -67.15 -23.79 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.688 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 m -76.24 -25.93 55.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.433 -0.792 . . . . 0.0 110.371 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 94.4 t -56.34 -55.11 45.74 Favored Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.27 -0.894 . . . . 0.0 110.712 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 43.9 Cg_endo -66.02 -26.24 51.03 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.06 1.032 . . . . 0.0 110.996 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 185' ' ' ILE . 74.2 t -67.57 -43.95 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -34.46 78.46 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.059 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.98 62.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.029 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.23 67.49 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.025 -0.422 . . . . 0.0 111.75 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.93 -24.09 66.04 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.257 -0.902 . . . . 0.0 111.073 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.38 -58.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 109.591 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.703 -1.141 . . . . 0.0 110.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -80.76 138.15 36.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.845 -0.535 . . . . 0.0 110.078 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.72 -91.2 0.19 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -121.82 137.58 27.42 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.901 -0.764 . . . . 0.0 110.03 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.16 100.45 0.99 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.304 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -93.33 -32.57 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -22.06 62.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.768 -0.582 . . . . 0.0 111.63 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.35 -37.19 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.646 -0.659 . . . . 0.0 109.887 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -75.64 -29.65 59.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.664 -0.648 . . . . 0.0 109.521 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.443 ' HA ' HD13 ' A' ' 178' ' ' LEU . 3.4 mm? -64.39 -42.22 96.25 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.02 -43.45 65.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.18 95.69 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 tp -67.3 -38.31 84.78 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.635 ' HA ' HG12 ' A' ' 185' ' ' ILE . 5.7 tt -61.76 -37.13 83.16 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.723 -0.61 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.2 t -66.58 -33.78 76.44 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.206 -0.934 . . . . 0.0 109.642 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.95 -33.68 68.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.155 -0.341 . . . . 0.0 110.8 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.635 HG12 ' HA ' ' A' ' 182' ' ' LEU . 12.9 pt -82.34 -23.53 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.536 -0.727 . . . . 0.0 111.574 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 189' ' ' VAL . 24.1 m -77.81 -28.15 50.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 38.6 t -59.41 -55.43 46.14 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.175 -0.953 . . . . 0.0 110.712 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 43.8 Cg_endo -66.21 -27.85 48.38 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.14 1.074 . . . . 0.0 111.257 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 186' ' ' THR . 0.4 OUTLIER -69.16 -34.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.297 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 194' ' ' VAL . 38.9 m -72.01 -39.1 69.43 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.63 68.37 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.968 -0.457 . . . . 0.0 110.326 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -79.91 -37.47 34.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -38.14 73.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.977 -0.452 . . . . 0.0 110.438 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 190' ' ' SER . 27.4 m -73.63 -9.42 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.58 -0.7 . . . . 0.0 111.858 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 mttp . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.16 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mttt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -78.54 134.08 37.3 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.636 -0.665 . . . . 0.0 110.332 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -97.22 71.12 0.74 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -121.37 118.45 29.91 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.759 -0.847 . . . . 0.0 110.643 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -80.99 63.35 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.756 1.398 . . . . 0.0 110.658 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -108.13 -12.57 15.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.21 -0.931 . . . . 0.0 111.907 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.6 m -65.14 -43.77 90.79 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.452 -0.78 . . . . 0.0 109.896 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.51 -34.02 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.61 -37.91 70.87 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -41.3 77.3 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.93 -46.75 77.07 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.55 98.44 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.38 -39.07 91.79 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 8.1 tp -61.73 -35.09 77.07 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.685 -0.634 . . . . 0.0 109.972 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 187' ' ' VAL . 6.4 t -71.22 -33.48 69.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.473 -0.767 . . . . 0.0 109.567 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 64.2 m -76.04 -36.41 59.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.92 -0.487 . . . . 0.0 110.324 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.477 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -81.13 -21.77 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.573 -0.704 . . . . 0.0 111.916 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -80.05 -19.74 46.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.325 -0.86 . . . . 0.0 111.378 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 183' ' ' SER . 73.0 t -60.42 -53.84 60.76 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.12 -0.987 . . . . 0.0 110.77 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 44.2 Cg_endo -66.55 -30.09 43.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.074 1.039 . . . . 0.0 111.093 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.21 -43.9 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.2 m -64.1 -38.9 92.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -64.66 -33.54 76.19 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.035 0.445 . . . . 0.0 110.552 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.53 75.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -75.49 -34.15 60.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.008 -0.433 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.9 m -78.23 -9.11 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.381 -0.824 . . . . 0.0 111.785 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.353 -0.842 . . . . 0.0 109.78 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.424 0.631 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -149.25 166.8 27.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.785 -0.572 . . . . 0.0 110.447 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.01 -155.1 13.4 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -96.51 112.89 61.48 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.583 -0.951 . . . . 0.0 110.25 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.96 61.47 6.71 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.738 1.388 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.17 -14.76 15.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.918 . . . . 0.0 111.794 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.0 m -60.34 -35.47 75.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.639 -0.663 . . . . 0.0 110.433 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.41 -35.76 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -76.9 -33.93 57.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.58 -47.49 66.65 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -44.71 84.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.12 89.18 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 185' ' ' ILE . 0.6 OUTLIER -65.94 -47.68 73.87 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.939 ' HA ' HD12 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -54.77 -23.04 16.12 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.972 -0.455 . . . . 0.0 111.139 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 t -82.95 -21.28 34.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.769 -1.207 . . . . 0.0 109.214 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 63.5 m -96.63 -30.89 13.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.79 -0.569 . . . . 0.0 111.337 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.939 HD12 ' HA ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -71.35 -17.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 121.121 -0.987 . . . . 0.0 111.278 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.784 ' N ' HD13 ' A' ' 185' ' ' ILE . 0.7 OUTLIER -71.37 -23.53 61.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.811 -0.556 . . . . 0.0 111.597 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.589 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 54.6 t -75.17 -55.3 2.27 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.134 -0.979 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -73.69 -7.31 19.99 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 O-C-N 123.167 1.088 . . . . 0.0 113.119 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.603 1.092 . . . . 0.0 110.381 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.2 m -66.63 -40.41 88.73 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.39 -34.67 78.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.2 88.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -71.13 -37.16 72.32 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.988 -0.445 . . . . 0.0 110.205 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 191' ' ' ALA . 34.7 m -85.0 -2.17 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.409 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.046 0.45 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -112.84 152.06 29.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.605 -0.684 . . . . 0.0 110.202 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.98 -38.72 1.58 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.134 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 173' ' ' PRO . 23.1 p90 -76.18 134.95 70.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 118.38 1.09 . . . . 0.0 111.557 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 172' ' ' PHE . 50.1 Cg_endo -85.22 86.33 1.11 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.573 1.302 . . . . 0.0 110.19 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -89.87 -30.41 17.92 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.462 -0.774 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 67.3 m -60.62 -25.28 66.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.92 -0.488 . . . . 0.0 111.498 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.1 tt -60.28 -40.76 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.868 -0.52 . . . . 0.0 110.514 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -81.72 -29.47 32.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.541 -0.724 . . . . 0.0 109.152 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 3.7 mm? -68.96 -44.88 72.06 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.65 -42.22 71.1 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.72 94.56 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 185' ' ' ILE . 7.7 tp -70.1 -40.26 75.03 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.43 -39.34 76.03 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 122.099 -0.376 . . . . 0.0 110.18 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 187' ' ' VAL . 9.2 t -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.5 t -67.36 -37.44 83.22 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 181' ' ' LEU . 17.3 mm -65.89 -36.05 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.659 -0.651 . . . . 0.0 110.359 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.5 m -76.44 -20.36 57.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.999 -0.438 . . . . 0.0 111.454 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 183' ' ' SER . 38.9 t -55.13 -56.83 23.89 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.3 Cg_endo -67.28 -25.61 42.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.033 1.017 . . . . 0.0 111.033 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.9 t -66.21 -47.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 194' ' ' VAL . 15.4 m -63.46 -36.96 85.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 120.894 0.378 . . . . 0.0 110.152 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.63 91.93 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.67 -33.9 73.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -69.74 -29.69 67.12 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 110.669 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 190' ' ' SER . 19.8 t -78.12 -34.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 109.571 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.719 -179.775 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.237 0.542 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -127.32 143.26 51.26 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.605 -0.684 . . . . 0.0 110.123 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.93 -115.74 1.01 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.59 134.8 24.7 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.825 -0.809 . . . . 0.0 110.682 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.88 69.72 7.82 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.89 1.468 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -105.34 -11.78 16.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.48 -0.763 . . . . 0.0 111.318 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.5 m -61.76 -37.27 83.66 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.26 -31.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -68.08 -39.83 82.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.88 -39.41 76.3 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -44.7 86.24 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.03 97.65 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.447 ' HA ' HD22 ' A' ' 181' ' ' LEU . 0.3 OUTLIER -61.9 -42.19 98.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.982 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.529 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.8 tt -61.99 -36.21 80.82 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.949 -0.469 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 t -65.89 -31.03 71.74 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.291 -0.881 . . . . 0.0 109.842 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.4 t -77.74 -36.98 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.94 -0.475 . . . . 0.0 110.075 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.529 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.5 pt -84.6 -18.74 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.56 -0.713 . . . . 0.0 112.164 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.8 t -78.41 -21.69 48.89 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 54.4 t -60.54 -53.65 62.44 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.117 -0.989 . . . . 0.0 110.731 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 44.9 Cg_endo -67.29 -31.02 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.03 1.016 . . . . 0.0 110.837 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.23 -40.92 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.3 m -66.46 -38.64 87.77 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -63.27 -34.7 78.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 120.999 0.428 . . . . 0.0 109.998 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.3 73.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -37.5 66.18 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.925 -0.484 . . . . 0.0 110.408 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -79.14 -1.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.579 -0.701 . . . . 0.0 111.964 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 tttp . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.219 179.838 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -83.45 144.9 29.28 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.852 -0.53 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.12 152.1 24.06 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -88.99 134.57 33.16 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.494 -1.003 . . . . 0.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.44 62.36 7.65 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.854 1.45 . . . . 0.0 110.825 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.66 -59.4 1.88 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 2.1 t -64.59 -26.31 68.35 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.092 -0.38 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.0 mm -63.51 -43.52 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.43 -34.04 69.94 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 16.8 mt -66.65 -44.95 80.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.41 -44.85 70.55 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.72 89.67 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -69.92 -45.65 67.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.997 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 -33.47 47.89 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.094 -0.379 . . . . 0.0 111.128 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.9 t -57.99 -27.7 63.71 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.779 -0.576 . . . . 0.0 110.584 179.352 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' CYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 188' ' ' PRO . 85.1 m -95.57 -7.41 37.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.03 -0.419 . . . . 0.0 111.458 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 181' ' ' LEU . 18.6 mm -104.88 -6.85 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.924 -1.11 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 61.5 m -110.17 -47.88 3.25 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.1 -1.0 . . . . 0.0 113.196 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 59.6 t -90.0 -55.37 0.29 Allowed Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.4 Cg_endo -67.05 -0.82 5.21 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 N-CA-C 114.827 1.049 . . . . 0.0 114.827 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.25 -33.62 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-N 119.382 0.992 . . . . 0.0 111.369 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -60.85 -43.67 98.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.869 -0.519 . . . . 0.0 109.739 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -67.6 -33.47 75.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.74 78.78 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 109.629 179.34 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -74.98 -35.2 62.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.886 -0.509 . . . . 0.0 111.094 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -79.93 -4.53 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.407 -0.808 . . . . 0.0 112.055 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.356 179.75 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.775 0.322 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -155.88 149.08 24.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.751 -0.593 . . . . 0.0 110.594 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.03 -54.99 1.79 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.43 122.85 86.98 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.732 -0.864 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.26 -177.67 4.05 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.876 1.461 . . . . 0.0 111.19 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 11.3 3.63 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.4 m -95.44 -29.07 14.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 110.227 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.6 mm -58.85 -43.41 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -71.33 -33.31 69.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.737 -0.602 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.14 -43.96 66.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.0 -43.86 81.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.13 99.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.809 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.6 tt -68.15 -37.99 81.63 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -23.61 64.98 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.544 -0.723 . . . . 0.0 111.459 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.9 t -56.93 -33.95 67.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 119.143 0.883 . . . . 0.0 110.099 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 57.7 m -82.01 -23.3 36.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.864 -0.522 . . . . 0.0 110.26 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.9 mm -88.93 -8.24 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.34 -0.85 . . . . 0.0 112.021 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 189' ' ' VAL . 7.0 m -52.63 -31.21 35.55 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.255 -0.903 . . . . 0.0 111.968 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.57 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 74.4 t -81.88 -57.46 0.51 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.428 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.4 Cg_endo -69.69 -4.73 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 O-C-N 122.991 0.995 . . . . 0.0 113.768 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 186' ' ' THR . 9.3 p -59.68 -38.48 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-N 119.634 1.107 . . . . 0.0 111.106 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 194' ' ' VAL . 66.0 m -70.07 -36.78 75.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 109.607 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 191' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -67.6 -27.78 67.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 120.776 0.322 . . . . 0.0 110.549 179.406 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.23 62.52 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -37.24 66.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.968 -0.457 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -77.11 -2.05 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.247 -0.908 . . . . 0.0 111.759 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.5 tttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.571 179.836 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.2 tttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 132.6 45.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.594 -0.691 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -100.56 -137.6 9.87 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.35 96.67 40.49 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.618 -0.931 . . . . 0.0 110.062 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.47 72.21 5.09 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.622 1.327 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -102.87 -30.53 10.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.668 -0.645 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.0 p -62.73 -33.27 74.77 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.872 -0.518 . . . . 0.0 110.635 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 mm -63.99 -39.32 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.83 -32.06 68.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.45 -44.13 83.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.03 -43.1 68.6 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.84 96.89 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.412 ' O ' HG12 ' A' ' 185' ' ' ILE . 3.2 tt -66.96 -43.82 82.1 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -36.0 79.28 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.95 -0.469 . . . . 0.0 109.841 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 187' ' ' VAL . 2.0 t -59.62 -38.95 82.68 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.26 -22.31 62.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.901 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 189' ' ' VAL . 31.0 mm -86.4 -32.29 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.1 m -77.95 -24.31 48.23 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.025 -0.422 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 12.1 t -58.53 -53.95 60.96 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.195 -0.941 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 46.6 Cg_endo -68.16 -15.45 42.86 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.201 1.106 . . . . 0.0 112.806 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 185' ' ' ILE . 77.8 t -63.34 -43.21 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.363 -0.836 . . . . 0.0 109.675 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.8 m -67.43 -33.46 75.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.731 -0.606 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -72.89 -13.75 61.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.953 -0.467 . . . . 0.0 111.46 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.26 -20.64 63.04 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.458 -0.776 . . . . 0.0 111.927 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.19 -23.55 64.08 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.176 -0.953 . . . . 0.0 111.904 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.8 p -50.84 -38.15 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.601 -0.687 . . . . 0.0 111.782 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.559 -0.734 . . . . 0.0 109.248 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 120.761 0.315 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -109.9 124.99 52.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.551 -0.718 . . . . 0.0 110.097 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.43 -101.21 0.14 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -68.04 134.8 91.7 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.823 -0.81 . . . . 0.0 110.98 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -77.8 9.2 3.06 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 O-C-N 123.695 1.366 . . . . 0.0 112.496 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -108.06 -19.24 13.56 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.061 -1.024 . . . . 0.0 111.175 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -60.34 -33.57 72.6 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.573 -0.704 . . . . 0.0 110.626 179.763 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 176' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 177' ' ' PHE . 30.2 pt -61.33 -37.61 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' N ' HG13 ' A' ' 176' ' ' ILE . 0.5 OUTLIER -79.5 -33.41 42.16 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.951 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 11.7 mt -67.42 -43.82 80.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.83 -46.27 69.01 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.84 88.81 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.205 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.42 -32.31 58.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.987 -0.445 . . . . 0.0 109.926 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.565 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.1 OUTLIER -57.47 -40.8 79.33 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.832 -0.542 . . . . 0.0 110.832 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -62.18 -35.84 80.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.544 -0.722 . . . . 0.0 109.515 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -76.04 -31.98 59.11 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.2 -0.312 . . . . 0.0 110.931 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.565 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 4.6 pt -90.52 -1.6 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 35.2 m -46.46 -45.02 17.93 Favored 'General case' 0 N--CA 1.512 2.631 0 CA-C-N 119.448 1.022 . . . . 0.0 112.024 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.486 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 40.3 t -76.23 -55.93 1.66 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.39 -0.819 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 185' ' ' ILE . 49.2 Cg_endo -69.86 -1.46 8.59 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.059 1.173 . . . . 0.0 114.109 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.89 -40.64 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-N 119.668 1.122 . . . . 0.0 112.046 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -70.08 -34.6 73.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.071 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.92 -24.66 61.67 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.097 -0.377 . . . . 0.0 110.522 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.48 -39.36 22.59 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.897 -0.502 . . . . 0.0 110.145 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.632 -0.668 . . . . 0.0 110.705 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.743 HG13 ' HE2' ' A' ' 195' ' ' LYS . 7.4 p -77.05 -25.52 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.757 . . . . 0.0 111.189 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.743 ' HE2' HG13 ' A' ' 194' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.087 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.98 0.419 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.89 103.39 11.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.679 -0.638 . . . . 0.0 110.248 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -138.23 -121.42 1.96 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -121.84 134.22 24.59 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.73 -0.865 . . . . 0.0 110.322 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -84.96 70.62 5.4 Favored 'Trans proline' 0 N--CA 1.489 1.213 0 O-C-N 123.777 1.409 . . . . 0.0 110.954 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -94.13 -33.02 13.5 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 39.0 m -57.11 -28.4 62.63 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 122.037 -0.415 . . . . 0.0 111.037 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 45.7 mm -62.96 -42.52 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -71.63 -33.82 69.27 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.8 mt -66.94 -47.17 72.49 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 14.5 mt -66.81 -43.03 84.89 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.42 96.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.455 HD13 ' C ' ' A' ' 181' ' ' LEU . 3.3 tm? -65.64 -41.48 92.56 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 185' ' ' ILE . 9.1 tp -59.74 -37.52 79.18 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.898 -0.502 . . . . 0.0 109.893 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.574 ' O ' HG23 ' A' ' 187' ' ' VAL . 15.8 t -66.82 -34.58 78.13 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.568 -0.708 . . . . 0.0 109.521 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 29.0 m -72.87 -41.59 64.57 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 182' ' ' LEU . 2.0 pt -80.07 -8.15 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.725 -0.609 . . . . 0.0 112.33 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.715 ' O ' HG22 ' A' ' 189' ' ' VAL . 2.7 t -102.23 2.93 37.74 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.117 -0.989 . . . . 0.0 111.787 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 183' ' ' SER . 63.8 t -73.37 -50.93 5.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 120.54 -1.35 . . . . 0.0 111.083 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.563 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.3 Cg_endo -75.3 -7.45 18.9 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.022 1.011 . . . . 0.0 113.259 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.715 HG22 ' O ' ' A' ' 186' ' ' THR . 11.3 m -64.32 -31.46 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 O-C-N 121.053 -1.029 . . . . 0.0 110.795 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.5 m -64.4 -44.11 92.31 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.18 -28.75 69.61 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.171 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.83 -33.33 66.11 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.785 -0.572 . . . . 0.0 109.772 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -79.08 -32.89 44.88 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.641 . . . . 0.0 110.974 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 191' ' ' ALA . 36.0 m -78.74 -11.05 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.415 -0.803 . . . . 0.0 112.097 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.786 0 CA-C-O 117.603 -1.189 . . . . 0.0 110.002 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 121.491 0.662 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 172' ' ' PHE . 0.3 OUTLIER -155.74 155.2 32.69 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.595 -0.691 . . . . 0.0 110.437 -179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -90.28 116.34 4.8 Favored Glycine 0 N--CA 1.497 2.7 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.406 ' CZ ' ' HB3' ' A' ' 2' ' ' LYS . 75.7 m-85 -110.44 110.33 57.95 Favored Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.644 -0.916 . . . . 0.0 110.754 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.98 -65.14 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.404 1.213 . . . . 0.0 110.359 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -95.76 -28.3 14.83 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 69.7 m -66.25 -19.6 65.87 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 122.096 -0.377 . . . . 0.0 110.903 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.53 -39.6 79.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-N 118.934 0.788 . . . . 0.0 109.558 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -75.97 -33.16 59.77 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.2 OUTLIER -67.47 -47.18 70.84 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.37 -43.69 85.25 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.29 -44.69 95.16 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -68.53 -39.08 81.32 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.569 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.8 OUTLIER -59.35 -37.97 79.21 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.033 -0.417 . . . . 0.0 110.858 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.4 t -61.27 -36.18 79.32 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.478 -0.764 . . . . 0.0 110.164 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.2 m -75.11 -35.06 61.77 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.183 -0.323 . . . . 0.0 110.428 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 10.7 pt -89.25 -4.71 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 121.549 -0.72 . . . . 0.0 112.772 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 m -48.51 -41.2 29.31 Favored 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.245 -0.909 . . . . 0.0 112.144 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.539 ' HB ' ' CD ' ' A' ' 188' ' ' PRO . 83.9 t -61.87 -62.01 6.67 Favored Pre-proline 0 N--CA 1.501 2.11 0 O-C-N 121.482 -0.761 . . . . 0.0 110.512 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.539 ' CD ' ' HB ' ' A' ' 187' ' ' VAL . 43.6 Cg_endo -64.26 -24.36 65.33 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 122.938 0.967 . . . . 0.0 111.824 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 185' ' ' ILE . 7.0 t -63.66 -51.66 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.121 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 48.7 m -66.46 -31.94 73.0 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 122.115 -0.365 . . . . 0.0 110.472 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -74.55 -34.38 62.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.932 -0.48 . . . . 0.0 110.328 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -26.99 62.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.188 -0.32 . . . . 0.0 110.727 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.68 -26.74 34.44 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.293 -0.88 . . . . 0.0 110.505 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 14.5 p -96.13 -41.45 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.546 -0.721 . . . . 0.0 110.984 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.561 -1.209 . . . . 0.0 110.836 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 39.3 mttt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.15 159.11 35.82 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.787 -0.57 . . . . 0.0 110.634 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -106.0 58.86 0.43 Allowed Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -121.21 120.86 28.9 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 122.061 -0.67 . . . . 0.0 110.299 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -77.37 -171.39 1.15 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 124.002 1.527 . . . . 0.0 111.244 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.0 t80 69.18 0.27 2.77 Favored 'General case' 0 N--CA 1.505 2.281 0 O-C-N 122.035 -0.415 . . . . 0.0 111.837 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -42.87 66.49 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 12.5 tt -64.32 -33.22 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -68.41 -36.36 78.99 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 0.1 OUTLIER -65.28 -41.26 94.35 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.471 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.42 -45.91 61.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.86 86.26 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 185' ' ' ILE . 4.2 tp -72.3 -37.04 69.07 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.457 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -50.87 -43.08 59.39 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.97 -0.456 . . . . 0.0 110.841 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.4 ' O ' HG23 ' A' ' 187' ' ' VAL . 7.2 t -62.53 -30.03 71.0 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.757 -0.59 . . . . 0.0 110.465 179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 83.4 m -76.76 -34.56 58.03 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 181' ' ' LEU . 19.7 mm -70.16 -33.92 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.766 -0.584 . . . . 0.0 110.456 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.2 p -69.99 -23.17 63.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.731 -0.606 . . . . 0.0 111.826 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.516 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 99.4 t -61.13 -57.23 27.54 Favored Pre-proline 0 N--CA 1.505 2.283 0 O-C-N 121.284 -0.885 . . . . 0.0 110.928 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 44.3 Cg_endo -65.99 -28.44 49.73 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.067 1.035 . . . . 0.0 110.947 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 185' ' ' ILE . 53.1 t -63.45 -43.39 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.2 m -62.73 -37.97 88.66 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.062 0.458 . . . . 0.0 109.766 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.04 -29.08 70.25 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 120.85 0.357 . . . . 0.0 110.85 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.51 -35.61 27.18 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.861 -0.524 . . . . 0.0 110.451 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -38.61 53.93 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.635 -0.666 . . . . 0.0 111.462 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.5 p -60.91 -35.55 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.322 0 O-C-N 121.399 -0.813 . . . . 0.0 110.965 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.728 179.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.0 tttm . . . . . 0 N--CA 1.496 1.867 0 CA-C-O 120.857 0.36 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -100.72 18.25 19.84 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.455 -0.778 . . . . 0.0 111.653 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.37 -95.99 0.32 Allowed Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -121.02 77.38 31.44 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.985 -0.715 . . . . 0.0 109.262 179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.78 58.77 6.12 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.27 1.313 . . . . 0.0 111.735 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -100.13 -8.44 23.67 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.369 -0.832 . . . . 0.0 110.718 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 1.5 t -59.29 -30.67 68.48 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.558 -0.714 . . . . 0.0 110.583 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.8 pp -59.44 -40.89 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.71 -34.03 60.35 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.426 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 27.8 mt -64.66 -41.15 96.31 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -44.84 68.38 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.96 97.74 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.2 OUTLIER -71.73 -38.12 70.49 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.806 -0.559 . . . . 0.0 109.778 179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.0 OUTLIER -62.41 -40.11 95.44 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.728 -0.608 . . . . 0.0 110.454 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.0 t -60.51 -36.67 78.93 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.767 -1.208 . . . . 0.0 110.077 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 8.7 t -71.03 -42.09 69.98 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 122.155 -0.341 . . . . 0.0 110.251 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -81.94 -18.11 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.627 -0.671 . . . . 0.0 112.095 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 85.3 m -86.3 -5.64 59.13 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.418 -0.801 . . . . 0.0 111.119 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.507 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 52.2 t -51.15 -51.41 68.32 Favored Pre-proline 0 N--CA 1.505 2.286 0 O-C-N 120.728 -1.233 . . . . 0.0 111.636 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.507 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.2 Cg_endo -72.21 -3.51 13.45 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 O-C-N 123.19 1.1 . . . . 0.0 113.577 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.438 HG22 HE22 ' A' ' 193' ' ' GLN . 0.8 OUTLIER -58.37 -29.19 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.106 -0.996 . . . . 0.0 111.23 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.606 ' O ' HG23 ' A' ' 194' ' ' VAL . 7.6 m -58.99 -44.56 91.64 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -65.55 -38.84 90.75 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.31 -34.93 69.23 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.438 HE22 HG22 ' A' ' 189' ' ' VAL . 0.7 OUTLIER -78.75 -32.59 46.75 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.747 -0.596 . . . . 0.0 110.153 179.451 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 190' ' ' SER . 46.5 t -63.9 -40.37 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 O-C-N 121.449 -0.782 . . . . 0.0 109.46 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.643 -0.694 . . . . 0.0 110.591 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.088 0.471 . . . . 0.0 110.494 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 173' ' ' PRO . 0.2 OUTLIER -91.95 122.97 34.96 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.275 -0.891 . . . . 0.0 110.502 -179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -87.52 -59.09 1.76 Allowed Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.07 84.0 32.37 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.654 -0.91 . . . . 0.0 109.376 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.407 ' HB3' ' HG2' ' A' ' 2' ' ' LYS . 48.3 Cg_endo -75.86 -31.28 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.463 0 O-C-N 123.645 1.34 . . . . 0.0 111.912 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -66.15 -42.06 89.54 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.717 -0.614 . . . . 0.0 111.172 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 32.0 p -62.58 -27.92 69.52 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 122.017 -0.427 . . . . 0.0 111.344 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 21.1 mm -64.39 -43.5 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -71.12 -30.84 67.01 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 178' ' ' LEU . 3.1 mm? -67.34 -45.88 75.1 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.39 -43.76 69.38 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.67 -44.03 96.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 185' ' ' ILE . 1.3 tt -68.12 -40.66 82.46 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 2.0 tt -56.87 -40.12 75.57 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.863 -0.523 . . . . 0.0 110.146 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.6 t -62.48 -37.19 85.02 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.6 m -68.83 -34.19 75.08 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 181' ' ' LEU . 14.9 mm -67.25 -33.56 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 O-C-N 121.642 -0.661 . . . . 0.0 109.555 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.3 m -67.59 -29.18 68.46 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.934 -0.479 . . . . 0.0 110.853 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 63.6 t -54.71 -59.08 11.46 Favored Pre-proline 0 N--CA 1.506 2.348 0 O-C-N 121.567 -0.708 . . . . 0.0 111.669 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 46.9 Cg_endo -67.75 -32.51 29.84 Favored 'Trans proline' 0 N--CA 1.495 1.574 0 O-C-N 122.994 0.997 . . . . 0.0 111.29 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 40.6 t -63.85 -43.78 97.93 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.6 m -69.52 -31.24 69.35 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 122.108 -0.37 . . . . 0.0 110.286 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -66.79 -28.13 68.13 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.761 -0.587 . . . . 0.0 110.209 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -87.32 -36.93 17.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.847 -0.533 . . . . 0.0 109.952 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -62.61 -40.83 98.17 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.635 -0.666 . . . . 0.0 110.261 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 13.7 p -67.91 -34.39 66.97 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.724 -0.61 . . . . 0.0 110.481 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 27.4 mmtm . . . . . 0 N--CA 1.501 2.1 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.148 179.859 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 8.9 mttp . . . . . 0 N--CA 1.498 1.959 0 CA-C-O 120.903 0.382 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.69 175.49 7.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.786 -0.571 . . . . 0.0 110.71 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 147.65 -134.94 5.37 Favored Glycine 0 N--CA 1.497 2.732 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -121.37 74.13 30.58 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.635 -0.92 . . . . 0.0 110.206 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.67 168.1 24.25 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 O-C-N 123.473 1.249 . . . . 0.0 110.677 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.9 t80 63.13 7.96 3.04 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 40.9 p -84.79 -40.96 16.59 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.846 -1.159 . . . . 0.0 109.44 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.0 pp -63.5 -34.12 65.55 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -76.84 -33.39 57.91 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 4.0 mt -62.7 -41.3 99.06 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 mp -73.47 -45.38 54.46 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.4 -41.19 84.38 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.467 ' O ' HG12 ' A' ' 185' ' ' ILE . 5.2 tt -76.79 -35.89 57.35 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.6 mt -55.59 -40.01 71.48 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.814 -0.554 . . . . 0.0 111.106 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.81 -33.36 73.98 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.532 -0.73 . . . . 0.0 109.514 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 3.6 t -76.16 -9.73 58.86 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.975 -0.453 . . . . 0.0 110.806 179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 189' ' ' VAL . 38.0 mm -101.34 -38.01 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 O-C-N 121.165 -0.96 . . . . 0.0 110.317 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.3 t -67.01 -32.27 73.38 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 122.016 -0.428 . . . . 0.0 111.464 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.502 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 49.4 t -67.09 -53.98 22.44 Favored Pre-proline 0 N--CA 1.503 2.182 0 O-C-N 121.212 -0.93 . . . . 0.0 111.417 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.502 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -70.28 -2.9 11.3 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 121.102 1.201 . . . . 0.0 114.24 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 185' ' ' ILE . 23.5 t -56.23 -49.36 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.436 0 CA-C-N 119.933 1.242 . . . . 0.0 110.76 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.4 m -60.17 -38.93 84.72 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.98 -0.45 . . . . 0.0 109.989 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -66.79 -37.42 84.52 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.42 -32.38 73.8 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.27 -25.5 46.77 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.795 -0.566 . . . . 0.0 110.984 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' A' ' 191' ' ' ALA . 32.6 m -97.0 0.67 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.386 0 O-C-N 121.405 -0.81 . . . . 0.0 112.384 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt . . . . . 0 N--CA 1.505 2.281 0 O-C-N 121.418 -0.801 . . . . 0.0 111.896 -179.826 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt . . . . . 0 N--CA 1.498 1.936 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -105.09 144.05 32.43 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.895 -0.503 . . . . 0.0 110.128 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.04 65.49 3.96 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -121.77 88.48 47.22 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.931 -0.746 . . . . 0.0 110.143 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -74.24 -7.28 19.56 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 O-C-N 123.631 1.332 . . . . 0.0 112.38 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -97.28 18.4 15.17 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.326 -0.858 . . . . 0.0 111.133 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 33.8 p -89.22 -24.44 22.13 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.018 -1.051 . . . . 0.0 110.77 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.2 mm -62.5 -46.82 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -72.9 -33.04 65.75 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 13.8 tp -65.8 -46.43 78.72 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.9 tp -69.27 -43.44 73.9 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.43 92.54 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tp -74.98 -33.99 61.94 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -60.32 -38.38 83.53 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.667 -0.646 . . . . 0.0 110.12 179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 4.1 t -57.36 -39.0 75.05 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-O 121.439 0.638 . . . . 0.0 109.768 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.11 -13.97 62.14 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.714 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 38.0 mm -97.53 -33.1 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.096 -1.002 . . . . 0.0 110.403 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.8 m -73.26 -35.78 66.25 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.049 -0.407 . . . . 0.0 111.049 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.542 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 42.7 t -59.62 -53.73 62.85 Favored Pre-proline 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.955 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.8 Cg_endo -72.9 -3.42 13.56 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 O-C-N 123.154 1.081 . . . . 0.0 113.222 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.2 p -56.99 -30.14 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 121.102 -0.999 . . . . 0.0 111.444 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 194' ' ' VAL . 11.7 m -61.28 -43.15 99.35 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.655 -0.653 . . . . 0.0 109.414 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.39 -34.74 70.65 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.91 -28.53 69.6 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -82.65 -32.72 28.08 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.583 -0.698 . . . . 0.0 109.716 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 190' ' ' SER . 58.1 t -78.49 -52.72 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.638 -0.664 . . . . 0.0 109.213 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.51 ' HD3' HG12 ' A' ' 194' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.907 0 CA-C-O 117.662 -1.161 . . . . 0.0 109.798 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 120.762 0.315 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.46 34.68 3.92 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.586 -0.697 . . . . 0.0 111.072 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 99.88 176.88 30.8 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -120.84 80.63 33.27 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.658 -0.907 . . . . 0.0 109.673 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.48 179.87 6.09 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.494 1.26 . . . . 0.0 111.41 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.641 ' O ' HD13 ' A' ' 178' ' ' LEU . 0.2 OUTLIER 61.78 8.74 2.54 Favored 'General case' 0 N--CA 1.507 2.396 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 58.9 m -97.37 -30.07 13.15 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.226 -0.921 . . . . 0.0 110.464 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 46.9 mm -61.72 -42.05 92.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -76.28 -30.25 57.73 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.772 -0.58 . . . . 0.0 109.871 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.641 HD13 ' O ' ' A' ' 174' ' ' PHE . 3.7 mp -70.67 -44.59 66.73 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 tt -71.41 -43.49 66.67 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.95 -44.51 97.16 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.2 tp -69.75 -36.56 75.91 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.648 ' HA ' HD12 ' A' ' 185' ' ' ILE . 1.0 OUTLIER -60.37 -39.11 86.04 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.715 -0.616 . . . . 0.0 109.766 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.2 t -61.12 -32.86 72.54 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.436 0.636 . . . . 0.0 109.523 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 69.7 m -76.72 -21.91 54.63 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 122.071 -0.393 . . . . 0.0 110.596 179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.648 HD12 ' HA ' ' A' ' 182' ' ' LEU . 37.4 mt -88.74 -31.43 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.183 -0.948 . . . . 0.0 110.46 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.9 p -73.9 -32.29 63.51 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.905 -0.497 . . . . 0.0 111.718 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.489 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 34.2 t -60.03 -53.94 60.29 Favored Pre-proline 0 N--CA 1.503 2.19 0 O-C-N 121.177 -0.952 . . . . 0.0 111.477 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.5 Cg_endo -71.82 -4.59 15.38 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 O-C-N 123.025 1.013 . . . . 0.0 113.408 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.85 -31.2 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 120.947 -1.095 . . . . 0.0 110.765 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.43 ' O ' HG22 ' A' ' 194' ' ' VAL . 47.5 m -67.51 -41.41 84.49 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.599 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -70.41 -29.89 66.62 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 120.851 0.358 . . . . 0.0 110.306 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -67.76 -32.7 73.48 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.876 -0.515 . . . . 0.0 110.848 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -92.04 -23.95 19.34 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.509 -0.744 . . . . 0.0 111.844 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.599 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -86.17 -1.47 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 O-C-N 121.03 -1.044 . . . . 0.0 111.881 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.6 ttmm . . . . . 0 N--CA 1.497 1.881 0 CA-C-O 117.734 -1.126 . . . . 0.0 110.177 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.5 tttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -161.97 -178.86 6.72 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-O 120.97 0.414 . . . . 0.0 110.484 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -99.48 -122.64 4.82 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -121.54 134.95 24.72 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.746 -0.855 . . . . 0.0 110.361 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.37 72.02 6.27 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 O-C-N 123.758 1.399 . . . . 0.0 110.652 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 33.8 p90 -111.25 -23.64 10.72 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.278 -0.888 . . . . 0.0 111.811 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.8 m -60.18 -35.1 74.59 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.806 -0.559 . . . . 0.0 111.167 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 177' ' ' PHE . 44.8 pt -63.24 -36.64 76.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.409 ' N ' HG13 ' A' ' 176' ' ' ILE . 68.6 m-85 -73.44 -32.69 64.52 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 182' ' ' LEU . 14.4 mt -63.43 -42.51 98.69 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 10.4 tp -72.24 -45.09 61.67 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.13 95.42 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tp -72.32 -33.49 67.4 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.49 HD22 HD11 ' A' ' 185' ' ' ILE . 0.1 OUTLIER -54.35 -45.36 72.72 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.902 -0.499 . . . . 0.0 109.993 179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.1 t -65.18 -34.44 78.38 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.28 -0.887 . . . . 0.0 109.675 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -74.15 -29.97 62.06 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.239 -0.288 . . . . 0.0 110.879 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.49 HD11 HD22 ' A' ' 182' ' ' LEU . 3.1 pt -93.81 -8.38 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.534 -0.729 . . . . 0.0 112.11 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 22.2 m -70.63 -46.39 63.42 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.131 -0.98 . . . . 0.0 109.813 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 72.3 t -60.75 -52.08 75.07 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.414 -0.803 . . . . 0.0 110.905 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.2 Cg_endo -70.23 -3.31 12.07 Favored 'Trans proline' 0 N--CA 1.499 1.83 0 C-N-CA 121.009 1.139 . . . . 0.0 113.589 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.9 p -58.11 -26.96 30.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.327 0 O-C-N 121.064 -1.023 . . . . 0.0 111.322 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.3 m -64.66 -41.87 95.79 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.538 -0.726 . . . . 0.0 109.304 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -69.21 -31.61 70.32 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 120.901 0.382 . . . . 0.0 110.16 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -75.5 -34.44 60.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.783 -0.573 . . . . 0.0 110.424 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.47 -42.27 68.32 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.614 -0.679 . . . . 0.0 111.111 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.16 -35.49 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.513 -0.742 . . . . 0.0 111.3 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.983 0 CA-C-O 118.548 -0.739 . . . . 0.0 110.233 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 120.682 0.277 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.22 158.64 35.14 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.504 -0.747 . . . . 0.0 110.307 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -66.19 -74.84 0.48 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.27 109.73 57.63 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.878 -0.778 . . . . 0.0 109.758 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -84.88 51.1 3.07 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 121.34 1.36 . . . . 0.0 111.283 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -104.02 4.5 34.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.208 -0.933 . . . . 0.0 111.545 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 12.9 p -79.86 -23.83 41.68 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.305 -0.872 . . . . 0.0 110.981 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.0 mt -56.95 -48.57 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 O-C-N 121.824 -0.548 . . . . 0.0 109.998 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.54 -30.16 61.65 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.713 -0.617 . . . . 0.0 109.635 179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.458 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 14.4 mt -69.35 -42.83 74.73 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 179' ' ' LEU . 3.7 mm? -69.79 -43.0 73.0 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.95 -46.26 90.06 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -66.62 -37.34 84.65 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.506 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 2.3 tt -61.05 -39.71 90.88 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.7 t -62.53 -35.59 79.89 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.254 -0.903 . . . . 0.0 109.781 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 46.5 m -75.94 -32.74 59.7 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 122.132 -0.355 . . . . 0.0 110.871 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.506 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -93.38 -8.07 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 O-C-N 121.442 -0.786 . . . . 0.0 112.315 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 17.4 m -84.62 -41.8 16.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.168 -0.958 . . . . 0.0 110.323 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.613 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 35.7 m -63.74 -36.61 22.59 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-O 117.861 -1.066 . . . . 0.0 113.034 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.613 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.9 Cg_endo -73.65 -11.3 24.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 CA-C-N 119.872 0.99 . . . . 0.0 112.236 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -60.36 -29.14 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.291 -0.88 . . . . 0.0 111.12 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.418 ' O ' HG22 ' A' ' 194' ' ' VAL . 71.1 m -60.52 -40.99 93.5 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.206 0.527 . . . . 0.0 109.764 179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -66.87 -30.41 70.57 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.02 -28.06 64.13 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.874 -0.516 . . . . 0.0 110.207 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -89.78 -33.13 16.65 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.416 -0.803 . . . . 0.0 110.495 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.5 m -79.63 -1.86 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 O-C-N 121.401 -0.812 . . . . 0.0 112.123 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 12.9 ttpt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.474 179.809 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 121.382 0.611 . . . . 0.0 110.579 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 26.2 pttt -153.66 175.94 12.67 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.488 -0.757 . . . . 0.0 110.5 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 92.25 144.34 13.78 Favored Glycine 0 N--CA 1.497 2.722 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -121.75 134.72 24.73 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.692 -0.887 . . . . 0.0 109.888 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.13 51.74 2.92 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 O-C-N 123.63 1.331 . . . . 0.0 112.119 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -103.86 -34.55 8.48 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.964 -1.085 . . . . 0.0 110.226 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 14.2 m -60.55 -30.05 69.53 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.899 -0.501 . . . . 0.0 110.659 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 2.7 tp -58.61 -39.01 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 122.068 -0.395 . . . . 0.0 110.173 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -78.28 -32.05 49.3 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.529 -0.732 . . . . 0.0 109.099 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.5 mp -68.25 -45.19 73.87 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.42 -41.12 73.35 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.61 -45.13 95.4 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.6 tp -71.82 -34.78 69.6 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 60.8 tp -61.36 -39.4 90.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.645 -0.659 . . . . 0.0 110.073 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.4 t -57.87 -38.74 76.27 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.711 -0.618 . . . . 0.0 109.706 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 96.8 m -64.71 -25.66 68.04 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 122.172 -0.33 . . . . 0.0 110.62 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 37.5 mm -86.41 -40.17 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.521 -0.737 . . . . 0.0 110.175 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 56.9 m -73.64 -32.55 64.08 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 122.008 -0.433 . . . . 0.0 111.939 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.414 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 5.5 t -53.08 -55.97 28.51 Favored Pre-proline 0 N--CA 1.507 2.411 0 CA-C-N 119.429 1.013 . . . . 0.0 111.17 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 45.6 Cg_endo -67.08 -31.4 36.84 Favored 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.26 1.137 . . . . 0.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -67.58 -43.4 87.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.5 m -61.11 -40.68 94.69 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.464 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -64.67 -32.34 73.96 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 122.144 -0.347 . . . . 0.0 110.212 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -72.38 -35.91 68.58 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.59 -36.23 65.51 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.933 -0.48 . . . . 0.0 110.682 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 191' ' ' ALA . 31.1 m -76.3 -10.24 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 121.16 -0.962 . . . . 0.0 111.749 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.477 -0.764 . . . . 0.0 109.916 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 42.2 mttt . . . . . 0 N--CA 1.498 1.952 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 132.83 51.88 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.554 -0.717 . . . . 0.0 110.189 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 96.66 -174.3 30.43 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -91.53 134.86 28.65 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.686 -0.89 . . . . 0.0 109.966 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.86 176.24 9.26 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 123.722 1.38 . . . . 0.0 111.493 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.14 13.64 5.95 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 122.106 -0.371 . . . . 0.0 111.815 -179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 20.9 p -96.86 -30.75 12.96 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.411 -0.806 . . . . 0.0 110.353 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.2 tp -55.25 -38.12 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 O-C-N 122.199 -0.313 . . . . 0.0 110.816 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -74.59 -33.41 62.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.57 -0.706 . . . . 0.0 109.55 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.86 -45.07 68.56 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.436 HD13 ' HA ' ' A' ' 179' ' ' LEU . 3.9 mm? -67.48 -43.73 80.26 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.18 -44.2 97.67 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.3 tt -66.14 -40.11 90.37 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.49 ' HA ' HD12 ' A' ' 185' ' ' ILE . 0.1 OUTLIER -60.59 -38.15 83.69 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.701 -0.624 . . . . 0.0 109.817 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.7 t -62.83 -37.35 86.44 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -67.91 -13.7 62.37 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.154 179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 182' ' ' LEU . 62.7 mt -97.18 -39.67 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.586 ' O ' HG12 ' A' ' 189' ' ' VAL . 30.0 m -72.87 -33.35 66.01 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.083 -0.386 . . . . 0.0 111.795 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 41.8 t -61.58 -53.72 58.78 Favored Pre-proline 0 N--CA 1.503 2.218 0 O-C-N 120.86 -1.15 . . . . 0.0 111.468 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.498 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -72.62 -8.8 23.1 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 O-C-N 123.062 1.033 . . . . 0.0 113.333 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 186' ' ' THR . 0.8 OUTLIER -65.06 -28.97 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.076 -1.015 . . . . 0.0 111.186 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.9 m -63.44 -38.9 92.92 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.732 -0.605 . . . . 0.0 109.937 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -64.53 -34.27 77.84 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.81 -29.66 70.83 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 122.228 -0.295 . . . . 0.0 110.438 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -85.99 -21.78 27.65 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.305 -0.872 . . . . 0.0 110.473 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 52.6 t -90.49 -53.12 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.381 -0.824 . . . . 0.0 109.365 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.891 0 CA-C-O 118.755 -0.641 . . . . 0.0 110.356 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 9.2 mttp . . . . . 0 N--CA 1.5 2.035 0 CA-C-O 120.998 0.428 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.6 156.99 40.05 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.694 -0.629 . . . . 0.0 109.675 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 178.1 -63.66 0.08 OUTLIER Glycine 0 N--CA 1.498 2.808 0 C-N-CA 119.964 -1.113 . . . . 0.0 111.365 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -76.78 133.6 69.85 Favored Pre-proline 0 N--CA 1.502 2.145 0 O-C-N 121.597 -0.943 . . . . 0.0 111.131 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.538 ' HB2' HD12 ' A' ' 176' ' ' ILE . 50.7 Cg_endo -84.31 72.06 5.24 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 121.509 1.473 . . . . 0.0 110.608 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -100.29 -16.9 17.54 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.432 -0.792 . . . . 0.0 112.282 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.559 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 46.3 m -73.5 -21.4 60.42 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.255 -0.903 . . . . 0.0 112.114 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.538 HD12 ' HB2' ' A' ' 173' ' ' PRO . 34.6 mt -58.39 -47.74 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.776 -0.578 . . . . 0.0 110.319 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -78.56 -27.28 45.78 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 13.2 mt -68.6 -47.28 67.12 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.45 -42.91 86.93 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.16 -47.73 84.72 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.7 tp -68.14 -35.15 77.63 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 120.114 -0.634 . . . . 0.0 109.647 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.733 HD13 HD11 ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.28 -39.2 86.04 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.639 -0.663 . . . . 0.0 109.985 179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.479 ' O ' HG22 ' A' ' 186' ' ' THR . 8.7 t -66.5 -35.14 79.51 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.367 -0.833 . . . . 0.0 109.817 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 7.7 t -74.34 -41.67 60.69 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.985 -0.447 . . . . 0.0 109.985 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.733 HD11 HD13 ' A' ' 182' ' ' LEU . 2.3 pp -79.1 -20.49 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.19 0 O-C-N 121.535 -0.728 . . . . 0.0 112.131 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 183' ' ' SER . 2.8 t -77.4 -17.71 57.92 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.15 -0.969 . . . . 0.0 111.878 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.514 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 86.9 t -59.72 -54.79 52.25 Favored Pre-proline 0 N--CA 1.505 2.32 0 O-C-N 121.066 -1.021 . . . . 0.0 110.75 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.514 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -67.55 -29.37 37.04 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.111 1.058 . . . . 0.0 110.977 179.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.59 -43.36 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 40.8 m -62.8 -39.16 93.41 Favored 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.056 0.455 . . . . 0.0 109.775 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.44 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -67.05 -24.27 65.96 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.119 -0.363 . . . . 0.0 110.663 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -78.35 -38.2 42.62 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.795 -0.566 . . . . 0.0 109.476 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -74.14 -35.67 64.09 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.522 -0.736 . . . . 0.0 110.562 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.44 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 26.9 m -73.39 -9.83 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 O-C-N 121.458 -0.776 . . . . 0.0 111.59 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 57.6 mttt . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.297 -0.877 . . . . 0.0 110.033 179.782 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.501 2.11 0 CA-C-O 120.859 0.361 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.96 74.98 1.54 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.549 -0.719 . . . . 0.0 110.093 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 67.83 59.87 6.18 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -82.01 131.79 55.75 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 121.437 -1.037 . . . . 0.0 110.129 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -82.65 78.04 3.49 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 123.898 1.473 . . . . 0.0 111.063 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -78.06 -35.77 49.17 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.403 -0.81 . . . . 0.0 110.48 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.19 -31.39 65.39 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.977 -0.452 . . . . 0.0 110.935 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 40.1 mm -60.77 -43.12 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -70.89 -31.32 67.93 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.86 -42.56 90.25 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.572 -0.705 . . . . 0.0 109.555 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.78 -44.69 69.6 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.14 -43.8 98.32 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD13 ' C ' ' A' ' 181' ' ' LEU . 3.2 tm? -67.07 -43.06 83.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.1 tt -58.28 -37.78 75.69 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.956 -0.465 . . . . 0.0 110.448 179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.417 ' O ' HG22 ' A' ' 187' ' ' VAL . 33.7 t -63.19 -39.23 94.04 Favored 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 39.2 m -67.57 -13.38 62.01 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.207 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 181' ' ' LEU . 43.1 mm -98.12 -35.19 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.22 -0.925 . . . . 0.0 110.166 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 38.1 m -76.47 -37.68 56.53 Favored 'General case' 0 N--CA 1.5 2.035 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.628 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.6 m -68.25 -38.96 14.61 Favored Pre-proline 0 N--CA 1.506 2.331 0 O-C-N 120.816 -1.178 . . . . 0.0 113.478 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.628 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.4 Cg_endo -71.55 -38.12 4.79 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 CA-C-N 119.798 0.963 . . . . 0.0 111.485 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.4 p -70.01 -33.41 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 C-N-CA 120.534 -0.467 . . . . 0.0 111.141 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 8.1 m -69.85 -40.01 76.06 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 195' ' ' LYS . . . -65.71 -46.29 79.52 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -57.98 -29.59 65.35 Favored 'General case' 0 N--CA 1.503 2.183 0 CA-C-O 120.681 0.277 . . . . 0.0 110.973 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -22.82 56.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.284 -0.885 . . . . 0.0 110.125 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.36 -54.08 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.516 -0.74 . . . . 0.0 109.58 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 191' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.077 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.57 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.097 0.475 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.1 tttm 51.23 59.19 4.78 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.589 -0.695 . . . . 0.0 110.94 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.51 146.52 5.41 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 110.341 -1.103 . . . . 0.0 110.341 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -81.77 135.27 49.14 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.75 -0.853 . . . . 0.0 109.877 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -77.18 67.94 7.52 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 123.723 1.381 . . . . 0.0 111.065 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -72.47 -21.17 61.26 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.322 -0.861 . . . . 0.0 111.126 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.61 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -61.78 -18.99 61.96 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 35.8 mm -58.35 -49.29 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 O-C-N 121.482 -0.761 . . . . 0.0 110.295 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -80.05 -28.79 39.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.886 -0.509 . . . . 0.0 109.669 179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 3.5 mm? -67.77 -43.44 79.8 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tp -70.45 -41.33 72.95 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.24 -44.22 95.43 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.9 -37.34 70.14 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.676 ' HA ' HD12 ' A' ' 185' ' ' ILE . 25.1 tp -60.41 -36.95 79.32 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.607 -0.683 . . . . 0.0 110.727 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.7 -37.43 81.62 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.494 -0.754 . . . . 0.0 109.403 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -71.2 -16.22 62.5 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 122.035 -0.416 . . . . 0.0 110.561 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.676 HD12 ' HA ' ' A' ' 182' ' ' LEU . 57.3 mt -95.07 -36.0 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.287 -0.883 . . . . 0.0 110.385 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.42 ' O ' HG12 ' A' ' 189' ' ' VAL . 5.8 t -75.14 -19.16 60.03 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.688 -0.632 . . . . 0.0 112.537 -179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 24.2 t -75.28 -55.09 2.28 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 120.924 -1.11 . . . . 0.0 110.82 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 45.8 Cg_endo -68.08 -28.8 34.4 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 122.963 0.98 . . . . 0.0 112.699 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.42 HG12 ' O ' ' A' ' 186' ' ' THR . 2.8 p -63.85 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.143 0 O-C-N 121.624 -0.673 . . . . 0.0 110.679 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.8 m -64.36 -43.52 94.28 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.507 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -72.08 -32.63 67.22 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.32 71.95 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.772 -0.58 . . . . 0.0 109.962 179.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -75.95 -37.3 58.8 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.786 -0.571 . . . . 0.0 109.633 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -91.79 1.73 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.8 tptt . . . . . 0 N--CA 1.506 2.355 0 O-C-N 121.39 -0.819 . . . . 0.0 112.145 -179.608 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt . . . . . 0 N--CA 1.499 2.017 0 CA-C-O 121.413 0.625 . . . . 0.0 110.526 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -160.88 130.68 4.97 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.399 -0.813 . . . . 0.0 110.309 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 65.53 50.34 55.42 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -105.66 134.38 19.74 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.767 -0.843 . . . . 0.0 109.894 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -74.91 63.68 5.92 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.913 1.48 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -116.38 -20.0 9.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.27 -0.894 . . . . 0.0 111.85 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.467 ' HA ' HD12 ' A' ' 178' ' ' LEU . 23.3 m -58.78 -34.35 71.34 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.668 -0.645 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 26.6 mt -64.17 -41.12 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -72.44 -32.09 66.01 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 175' ' ' SER . 27.9 mt -62.76 -44.82 95.2 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.29 -44.65 71.38 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.58 94.63 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.8 tp -73.19 -34.01 65.73 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.877 179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.527 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.4 OUTLIER -60.11 -41.84 93.44 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.501 -0.749 . . . . 0.0 110.065 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -61.93 -34.67 76.52 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.231 -0.918 . . . . 0.0 109.678 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 43.8 m -78.02 -28.82 49.19 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.244 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.527 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.5 pp -96.85 -17.64 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.389 0 O-C-N 121.286 -0.883 . . . . 0.0 112.152 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 24.7 m -74.45 -40.43 61.91 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.365 -0.834 . . . . 0.0 109.96 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.521 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 69.2 t -59.63 -52.46 73.81 Favored Pre-proline 0 N--CA 1.502 2.158 0 O-C-N 121.495 -0.753 . . . . 0.0 111.164 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 50.8 Cg_endo -71.09 -3.27 12.54 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 120.977 1.118 . . . . 0.0 113.731 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.73 -28.86 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-N 119.715 1.143 . . . . 0.0 111.173 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 14.2 m -61.4 -40.13 93.27 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.505 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -84.56 -13.37 51.97 Favored 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.155 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -77.89 -44.93 25.58 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.447 -0.783 . . . . 0.0 110.32 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.85 -32.88 71.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.536 -0.728 . . . . 0.0 110.862 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.505 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.3 m -81.28 -2.8 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.557 -0.715 . . . . 0.0 111.845 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 117.8 -1.095 . . . . 0.0 109.988 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.864 0.364 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 29.5 mtpt -95.74 128.67 42.82 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -148.25 70.73 0.33 Allowed Glycine 0 N--CA 1.495 2.621 0 N-CA-C 108.934 -1.667 . . . . 0.0 108.934 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -121.02 127.78 26.05 Favored Pre-proline 0 N--CA 1.497 1.897 0 O-C-N 121.973 -0.722 . . . . 0.0 109.972 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.17 177.09 9.08 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 123.864 1.455 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.618 ' O ' HD23 ' A' ' 178' ' ' LEU . 2.6 t80 63.59 9.43 4.27 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.957 -0.464 . . . . 0.0 112.085 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 1.7 t -92.23 -27.4 17.66 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.818 -1.176 . . . . 0.0 109.901 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 5.1 tp -61.42 -41.01 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -75.76 -30.36 59.15 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.618 HD23 ' O ' ' A' ' 174' ' ' PHE . 2.4 mm? -67.0 -44.88 79.21 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 13.2 tp -69.33 -42.59 75.12 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.93 92.66 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.0 tt -64.35 -38.49 91.2 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.721 HD13 HD11 ' A' ' 185' ' ' ILE . 0.3 OUTLIER -58.76 -38.82 79.29 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.5 t -67.73 -34.94 77.84 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.573 -0.705 . . . . 0.0 109.724 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.1 t -75.12 -34.05 61.63 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.927 -0.483 . . . . 0.0 110.336 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.721 HD11 HD13 ' A' ' 182' ' ' LEU . 2.6 pp -89.2 -7.49 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.524 -0.735 . . . . 0.0 112.475 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.581 ' O ' HG12 ' A' ' 189' ' ' VAL . 5.1 t -95.68 -24.91 16.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.172 -0.955 . . . . 0.0 111.456 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.575 ' CG2' ' HD3' ' A' ' 188' ' ' PRO . 34.2 m -73.25 -32.71 1.73 Allowed Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 120.964 -1.085 . . . . 0.0 112.706 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.575 ' HD3' ' CG2' ' A' ' 187' ' ' VAL . 50.1 Cg_endo -76.34 -29.74 5.94 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 CA-C-N 119.677 0.921 . . . . 0.0 111.629 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 186' ' ' THR . 0.9 OUTLIER -62.52 -29.83 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.853 -0.529 . . . . 0.0 110.583 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.9 m -67.69 -36.27 80.36 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.641 -0.662 . . . . 0.0 109.266 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.567 ' HA ' ' CG2' ' A' ' 194' ' ' VAL . . . -74.36 -13.5 60.75 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 122.139 -0.35 . . . . 0.0 111.343 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -71.38 -45.65 62.29 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.339 -0.851 . . . . 0.0 110.946 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -72.4 -30.0 64.25 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.712 -0.618 . . . . 0.0 111.602 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.567 ' CG2' ' HA ' ' A' ' 191' ' ' ALA . 35.1 m -81.4 -1.22 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.282 -0.886 . . . . 0.0 112.155 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.316 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.836 0.351 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.2 tttm -80.48 79.84 7.02 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.431 0.634 . . . . 0.0 109.519 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 172.39 -70.84 0.11 Allowed Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -121.5 83.62 41.22 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.85 -0.794 . . . . 0.0 110.064 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -84.48 -172.75 1.33 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 123.726 1.382 . . . . 0.0 110.884 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.11 13.54 4.78 Favored 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.08 -31.9 12.25 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.247 -0.908 . . . . 0.0 110.314 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 16.3 tt -54.7 -38.36 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 122.079 -0.388 . . . . 0.0 110.638 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -73.83 -33.87 64.32 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 6.5 tp -63.9 -41.54 97.68 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.4 mp -65.84 -44.39 85.69 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.88 -43.86 97.87 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -63.61 -40.44 96.93 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.661 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.482 ' O ' HG13 ' A' ' 185' ' ' ILE . 1.4 mp -64.1 -30.5 71.56 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 122.142 -0.348 . . . . 0.0 111.414 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -74.01 -33.92 63.96 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.983 -1.073 . . . . 0.0 109.209 179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 56.8 m -73.37 -43.22 61.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 122.135 -0.353 . . . . 0.0 110.159 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.517 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.3 pp -67.15 -23.79 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.688 . . . . 0.0 111.361 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 21.8 m -76.24 -25.93 55.5 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.433 -0.792 . . . . 0.0 110.371 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.474 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 94.4 t -56.34 -55.11 45.74 Favored Pre-proline 0 N--CA 1.503 2.199 0 O-C-N 121.27 -0.894 . . . . 0.0 110.712 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 43.9 Cg_endo -66.02 -26.24 51.03 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 O-C-N 123.06 1.032 . . . . 0.0 110.996 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 185' ' ' ILE . 74.2 t -67.57 -43.95 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 10.3 m -64.93 -34.46 78.46 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 120.892 0.377 . . . . 0.0 110.059 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -70.84 -21.98 62.37 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.936 -0.477 . . . . 0.0 111.029 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -60.54 -27.23 67.49 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 122.025 -0.422 . . . . 0.0 111.75 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -66.93 -24.09 66.04 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.257 -0.902 . . . . 0.0 111.073 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 38.9 t -106.38 -58.72 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.418 -0.801 . . . . 0.0 109.591 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 117.703 -1.141 . . . . 0.0 110.384 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.5 tppt? -80.76 138.15 36.28 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.845 -0.535 . . . . 0.0 110.078 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -140.72 -91.2 0.19 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -121.82 137.58 27.42 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.901 -0.764 . . . . 0.0 110.03 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.16 100.45 0.99 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.62 1.326 . . . . 0.0 110.304 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -93.33 -32.57 14.24 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 110.707 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.47 -22.06 62.71 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.768 -0.582 . . . . 0.0 111.63 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 6.4 tp -60.35 -37.19 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.646 -0.659 . . . . 0.0 109.887 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -75.64 -29.65 59.21 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.664 -0.648 . . . . 0.0 109.521 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 178' ' ' LEU . 3.4 mm? -64.39 -42.22 96.25 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.02 -43.45 65.0 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.16 -45.18 95.69 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.2 tp -67.3 -38.31 84.78 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.635 ' HA ' HG12 ' A' ' 185' ' ' ILE . 5.7 tt -61.76 -37.13 83.16 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.723 -0.61 . . . . 0.0 109.89 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.2 t -66.58 -33.78 76.44 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.206 -0.934 . . . . 0.0 109.642 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 58.3 m -71.95 -33.68 68.4 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 122.155 -0.341 . . . . 0.0 110.8 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.635 HG12 ' HA ' ' A' ' 182' ' ' LEU . 12.9 pt -82.34 -23.53 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.536 -0.727 . . . . 0.0 111.574 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.43 ' O ' HG12 ' A' ' 189' ' ' VAL . 24.1 m -77.81 -28.15 50.28 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.457 -0.777 . . . . 0.0 110.653 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.429 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 38.6 t -59.41 -55.43 46.14 Favored Pre-proline 0 N--CA 1.503 2.204 0 O-C-N 121.175 -0.953 . . . . 0.0 110.712 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 43.8 Cg_endo -66.21 -27.85 48.38 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 O-C-N 123.14 1.074 . . . . 0.0 111.257 179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 186' ' ' THR . 0.4 OUTLIER -69.16 -34.04 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.667 -0.646 . . . . 0.0 109.297 179.27 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.466 ' O ' HG22 ' A' ' 194' ' ' VAL . 38.9 m -72.01 -39.1 69.43 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -65.0 -26.63 68.37 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.968 -0.457 . . . . 0.0 110.326 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -79.91 -37.47 34.61 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -38.14 73.63 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.977 -0.452 . . . . 0.0 110.438 179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 190' ' ' SER . 27.4 m -73.63 -9.42 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 O-C-N 121.58 -0.7 . . . . 0.0 111.858 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 15.8 mttp . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 117.586 -1.197 . . . . 0.0 110.16 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.6 mttt . . . . . 0 N--CA 1.496 1.873 0 CA-C-O 120.943 0.401 . . . . 0.0 110.359 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -78.54 134.08 37.3 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.636 -0.665 . . . . 0.0 110.332 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -97.22 71.12 0.74 Allowed Glycine 0 N--CA 1.497 2.719 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -121.37 118.45 29.91 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.759 -0.847 . . . . 0.0 110.643 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -80.99 63.35 8.77 Favored 'Trans proline' 0 N--CA 1.492 1.422 0 O-C-N 123.756 1.398 . . . . 0.0 110.658 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -108.13 -12.57 15.09 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.21 -0.931 . . . . 0.0 111.907 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 44.6 m -65.14 -43.77 90.79 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.452 -0.78 . . . . 0.0 109.896 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 1.5 pp -62.51 -34.02 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -71.61 -37.91 70.87 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -41.3 77.3 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 tt -65.93 -46.75 77.07 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.94 -42.55 98.44 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 5.5 tp -65.38 -39.07 91.79 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.477 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 8.1 tp -61.73 -35.09 77.07 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.685 -0.634 . . . . 0.0 109.972 179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 187' ' ' VAL . 6.4 t -71.22 -33.48 69.93 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.473 -0.767 . . . . 0.0 109.567 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 64.2 m -76.04 -36.41 59.07 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.92 -0.487 . . . . 0.0 110.324 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.477 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 1.3 pp -81.13 -21.77 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 O-C-N 121.573 -0.704 . . . . 0.0 111.916 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 t -80.05 -19.74 46.89 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.325 -0.86 . . . . 0.0 111.378 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 183' ' ' SER . 73.0 t -60.42 -53.84 60.76 Favored Pre-proline 0 N--CA 1.504 2.247 0 O-C-N 121.12 -0.987 . . . . 0.0 110.77 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.476 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 44.2 Cg_endo -66.55 -30.09 43.5 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 O-C-N 123.074 1.039 . . . . 0.0 111.093 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.21 -43.9 91.66 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.966 -0.754 . . . . 0.0 108.966 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 42.2 m -64.1 -38.9 92.73 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.498 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -64.66 -33.54 76.19 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.035 0.445 . . . . 0.0 110.552 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.38 -35.53 75.9 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.881 -0.512 . . . . 0.0 109.64 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.6 mm100 -75.49 -34.15 60.84 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 122.008 -0.433 . . . . 0.0 111.171 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.9 m -78.23 -9.11 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 O-C-N 121.381 -0.824 . . . . 0.0 111.785 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 195' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 O-C-N 121.353 -0.842 . . . . 0.0 109.78 179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.925 0 CA-C-O 121.424 0.631 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -149.25 166.8 27.82 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.785 -0.572 . . . . 0.0 110.447 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -178.01 -155.1 13.4 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 110.351 -1.099 . . . . 0.0 110.351 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -96.51 112.89 61.48 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.583 -0.951 . . . . 0.0 110.25 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -83.96 61.47 6.71 Favored 'Trans proline' 0 N--CA 1.489 1.232 0 O-C-N 123.738 1.388 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -104.17 -14.76 15.74 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.232 -0.918 . . . . 0.0 111.794 179.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 50.0 m -60.34 -35.47 75.74 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.639 -0.663 . . . . 0.0 110.433 179.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 20.9 tt -60.41 -35.76 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.466 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -76.9 -33.93 57.75 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 20.6 mt -68.58 -47.49 66.65 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.86 -44.71 84.62 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.47 -44.12 89.18 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.756 ' O ' HG23 ' A' ' 185' ' ' ILE . 0.6 OUTLIER -65.94 -47.68 73.87 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.939 ' HA ' HD12 ' A' ' 185' ' ' ILE . 0.9 OUTLIER -54.77 -23.04 16.12 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 121.972 -0.455 . . . . 0.0 111.139 179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 32.8 t -82.95 -21.28 34.11 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.769 -1.207 . . . . 0.0 109.214 178.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 63.5 m -96.63 -30.89 13.01 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.79 -0.569 . . . . 0.0 111.337 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.939 HD12 ' HA ' ' A' ' 182' ' ' LEU . 0.0 OUTLIER -71.35 -17.7 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.62 0 O-C-N 121.121 -0.987 . . . . 0.0 111.278 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.784 ' N ' HD13 ' A' ' 185' ' ' ILE . 0.7 OUTLIER -71.37 -23.53 61.92 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.811 -0.556 . . . . 0.0 111.597 179.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.589 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 54.6 t -75.17 -55.3 2.27 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.134 -0.979 . . . . 0.0 110.889 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.589 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 51.1 Cg_endo -73.69 -7.31 19.99 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 O-C-N 123.167 1.088 . . . . 0.0 113.119 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 1.5 p -64.59 -36.18 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.188 0 CA-C-N 119.603 1.092 . . . . 0.0 110.381 179.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 4.2 m -66.63 -40.41 88.73 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -65.39 -34.67 78.85 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.82 -38.2 88.28 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.408 -0.589 . . . . 0.0 109.408 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.3 mm100 -71.13 -37.16 72.32 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.988 -0.445 . . . . 0.0 110.205 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 191' ' ' ALA . 34.7 m -85.0 -2.17 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.239 0 O-C-N 121.461 -0.774 . . . . 0.0 111.409 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 6.8 tppt? . . . . . 0 N--CA 1.499 1.993 0 O-C-N 121.368 -0.833 . . . . 0.0 110.398 179.814 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.7 mttt . . . . . 0 N--CA 1.499 2.008 0 CA-C-O 121.046 0.45 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -112.84 152.06 29.67 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.605 -0.684 . . . . 0.0 110.202 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 139.98 -38.72 1.58 Allowed Glycine 0 N--CA 1.497 2.721 0 C-N-CA 120.409 -0.901 . . . . 0.0 111.134 179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 173' ' ' PRO . 23.1 p90 -76.18 134.95 70.23 Favored Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 118.38 1.09 . . . . 0.0 111.557 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 172' ' ' PHE . 50.1 Cg_endo -85.22 86.33 1.11 Allowed 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.573 1.302 . . . . 0.0 110.19 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -89.87 -30.41 17.92 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.462 -0.774 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 67.3 m -60.62 -25.28 66.15 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.92 -0.488 . . . . 0.0 111.498 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 18.1 tt -60.28 -40.76 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 O-C-N 121.868 -0.52 . . . . 0.0 110.514 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -81.72 -29.47 32.92 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.541 -0.724 . . . . 0.0 109.152 179.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 3.7 mm? -68.96 -44.88 72.06 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.435 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 tp -70.65 -42.22 71.1 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.72 94.56 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 179.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 185' ' ' ILE . 7.7 tp -70.1 -40.26 75.03 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.3 tt -57.43 -39.34 76.03 Favored 'General case' 0 N--CA 1.507 2.375 0 O-C-N 122.099 -0.376 . . . . 0.0 110.18 179.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.501 ' O ' HG23 ' A' ' 187' ' ' VAL . 9.2 t -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.5 t -67.36 -37.44 83.22 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 181' ' ' LEU . 17.3 mm -65.89 -36.05 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 O-C-N 121.659 -0.651 . . . . 0.0 110.359 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 31.5 m -76.44 -20.36 57.13 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.999 -0.438 . . . . 0.0 111.454 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 183' ' ' SER . 38.9 t -55.13 -56.83 23.89 Favored Pre-proline 0 N--CA 1.505 2.317 0 O-C-N 121.234 -0.917 . . . . 0.0 110.605 179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.441 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.3 Cg_endo -67.28 -25.61 42.5 Favored 'Trans proline' 0 N--CA 1.492 1.424 0 O-C-N 123.033 1.017 . . . . 0.0 111.033 179.484 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 79.9 t -66.21 -47.99 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.64 ' O ' HG23 ' A' ' 194' ' ' VAL . 15.4 m -63.46 -36.96 85.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 120.894 0.378 . . . . 0.0 110.152 179.524 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -63.11 -38.63 91.93 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -69.67 -33.9 73.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -69.74 -29.69 67.12 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.546 -0.721 . . . . 0.0 110.669 179.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.64 HG23 ' O ' ' A' ' 190' ' ' SER . 19.8 t -78.12 -34.69 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 109.571 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.4 tpmp? . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.719 -179.775 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.923 0 CA-C-O 121.237 0.542 . . . . 0.0 110.382 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.7 mttp -127.32 143.26 51.26 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.605 -0.684 . . . . 0.0 110.123 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -144.93 -115.74 1.01 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -121.59 134.8 24.7 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.825 -0.809 . . . . 0.0 110.682 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.88 69.72 7.82 Favored 'Trans proline' 0 N--CA 1.488 1.191 0 O-C-N 123.89 1.468 . . . . 0.0 110.376 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -105.34 -11.78 16.33 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.48 -0.763 . . . . 0.0 111.318 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 18.5 m -61.76 -37.27 83.66 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.324 -0.86 . . . . 0.0 109.038 179.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.26 -31.57 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -68.08 -39.83 82.81 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 5.6 mp -69.88 -39.41 76.3 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.04 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.5 -44.7 86.24 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 178.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.84 -44.03 97.65 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 181' ' ' LEU . 0.3 OUTLIER -61.9 -42.19 98.78 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.982 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.529 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 1.8 tt -61.99 -36.21 80.82 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.949 -0.469 . . . . 0.0 110.386 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.8 t -65.89 -31.03 71.74 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.291 -0.881 . . . . 0.0 109.842 179.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.4 t -77.74 -36.98 50.22 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.94 -0.475 . . . . 0.0 110.075 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.529 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 2.5 pt -84.6 -18.74 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 121.56 -0.713 . . . . 0.0 112.164 -179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 4.8 t -78.41 -21.69 48.89 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.389 179.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.449 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 54.4 t -60.54 -53.65 62.44 Favored Pre-proline 0 N--CA 1.505 2.306 0 O-C-N 121.117 -0.989 . . . . 0.0 110.731 179.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 44.9 Cg_endo -67.29 -31.02 36.31 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 O-C-N 123.03 1.016 . . . . 0.0 110.837 179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.23 -40.92 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.353 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 43.3 m -66.46 -38.64 87.77 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.493 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -63.27 -34.7 78.25 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-O 120.999 0.428 . . . . 0.0 109.998 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.44 -35.3 73.29 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.3 -37.5 66.18 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.925 -0.484 . . . . 0.0 110.408 179.58 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.493 HG22 ' HA ' ' A' ' 191' ' ' ALA . 35.7 m -79.14 -1.83 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 O-C-N 121.579 -0.701 . . . . 0.0 111.964 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.1 tttp . . . . . 0 N--CA 1.497 1.882 0 CA-C-O 117.822 -1.085 . . . . 0.0 110.219 179.838 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.9 tttm . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.0 ttpt -83.45 144.9 29.28 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.852 -0.53 . . . . 0.0 109.962 179.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -150.12 152.1 24.06 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -88.99 134.57 33.16 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.494 -1.003 . . . . 0.0 110.539 179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -77.44 62.36 7.65 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 O-C-N 123.854 1.45 . . . . 0.0 110.825 179.859 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.66 -59.4 1.88 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.361 -0.837 . . . . 0.0 109.872 179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 2.1 t -64.59 -26.31 68.35 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 122.092 -0.38 . . . . 0.0 110.627 179.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 29.0 mm -63.51 -43.52 98.37 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.27 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -71.43 -34.04 69.94 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.162 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 16.8 mt -66.65 -44.95 80.52 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.302 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tp -69.41 -44.85 70.55 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.282 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.78 -42.72 89.67 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 185' ' ' ILE . 0.8 OUTLIER -69.92 -45.65 67.06 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.997 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.71 -33.47 47.89 Favored 'General case' 0 N--CA 1.507 2.41 0 O-C-N 122.094 -0.379 . . . . 0.0 111.128 179.7 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.9 t -57.99 -27.7 63.71 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.779 -0.576 . . . . 0.0 110.584 179.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 188' ' ' PRO . 85.1 m -95.57 -7.41 37.91 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 122.03 -0.419 . . . . 0.0 111.458 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 181' ' ' LEU . 18.6 mm -104.88 -6.85 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 O-C-N 120.924 -1.11 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 61.5 m -110.17 -47.88 3.25 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.1 -1.0 . . . . 0.0 113.196 -179.361 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 59.6 t -90.0 -55.37 0.29 Allowed Pre-proline 0 N--CA 1.505 2.287 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -178.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.464 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 45.4 Cg_endo -67.05 -0.82 5.21 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 N-CA-C 114.827 1.049 . . . . 0.0 114.827 -178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 29.2 m -55.25 -33.62 31.19 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-N 119.382 0.992 . . . . 0.0 111.369 179.71 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -60.85 -43.67 98.05 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.869 -0.519 . . . . 0.0 109.739 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.52 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -67.6 -33.47 75.07 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.408 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -65.98 -34.74 78.78 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.849 -0.532 . . . . 0.0 109.629 179.34 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.8 mm-40 -74.98 -35.2 62.07 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.886 -0.509 . . . . 0.0 111.094 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.52 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -79.93 -4.53 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.364 0 O-C-N 121.407 -0.808 . . . . 0.0 112.055 -179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.639 -1.172 . . . . 0.0 110.356 179.75 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 120.775 0.322 . . . . 0.0 110.392 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -155.88 149.08 24.54 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.751 -0.593 . . . . 0.0 110.594 -179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -92.03 -54.99 1.79 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 110.128 -1.189 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.43 122.85 86.98 Favored Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 121.732 -0.864 . . . . 0.0 110.375 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.26 -177.67 4.05 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.876 1.461 . . . . 0.0 111.19 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.42 11.3 3.63 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 19.4 m -95.44 -29.07 14.6 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.203 -0.935 . . . . 0.0 110.227 179.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 14.6 mm -58.85 -43.41 88.26 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 15.8 t80 -71.33 -33.31 69.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.737 -0.602 . . . . 0.0 109.391 179.355 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.14 -43.96 66.5 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.0 -43.86 81.84 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 179.059 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -61.26 -43.13 99.39 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 178.809 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.6 tt -68.15 -37.99 81.63 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.157 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 -23.61 64.98 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.544 -0.723 . . . . 0.0 111.459 179.882 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.9 t -56.93 -33.95 67.5 Favored 'General case' 0 N--CA 1.505 2.319 0 CA-C-N 119.143 0.883 . . . . 0.0 110.099 179.494 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 57.7 m -82.01 -23.3 36.04 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.864 -0.522 . . . . 0.0 110.26 179.309 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 19.9 mm -88.93 -8.24 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.34 -0.85 . . . . 0.0 112.021 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.401 ' O ' HG12 ' A' ' 189' ' ' VAL . 7.0 m -52.63 -31.21 35.55 Favored 'General case' 0 N--CA 1.509 2.48 0 O-C-N 121.255 -0.903 . . . . 0.0 111.968 -179.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.57 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 74.4 t -81.88 -57.46 0.51 Allowed Pre-proline 0 N--CA 1.496 1.874 0 O-C-N 121.461 -0.774 . . . . 0.0 110.428 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.57 ' HD3' ' HB ' ' A' ' 187' ' ' VAL . 49.4 Cg_endo -69.69 -4.73 14.56 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 O-C-N 122.991 0.995 . . . . 0.0 113.768 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.401 HG12 ' O ' ' A' ' 186' ' ' THR . 9.3 p -59.68 -38.48 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 CA-C-N 119.634 1.107 . . . . 0.0 111.106 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 194' ' ' VAL . 66.0 m -70.07 -36.78 75.18 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.705 -0.622 . . . . 0.0 109.607 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . 0.513 ' HA ' HG22 ' A' ' 194' ' ' VAL . . . -67.6 -27.78 67.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 120.776 0.322 . . . . 0.0 110.549 179.406 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.23 62.52 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.35 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.17 -37.24 66.61 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.968 -0.457 . . . . 0.0 110.603 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 191' ' ' ALA . 33.7 m -77.11 -2.05 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.384 0 O-C-N 121.247 -0.908 . . . . 0.0 111.759 179.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 16.5 tttt . . . . . 0 N--CA 1.498 1.939 0 CA-C-O 117.684 -1.15 . . . . 0.0 110.571 179.836 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 10.2 tttt . . . . . 0 N--CA 1.498 1.97 0 CA-C-O 120.921 0.391 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 132.6 45.86 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.594 -0.691 . . . . 0.0 110.435 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -100.56 -137.6 9.87 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -113.35 96.67 40.49 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.618 -0.931 . . . . 0.0 110.062 179.89 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -84.47 72.21 5.09 Favored 'Trans proline' 0 N--CA 1.487 1.096 0 O-C-N 123.622 1.327 . . . . 0.0 110.183 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -102.87 -30.53 10.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.668 -0.645 . . . . 0.0 111.095 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.0 p -62.73 -33.27 74.77 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.872 -0.518 . . . . 0.0 110.635 179.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . . . . . . . . . 32.9 mm -63.99 -39.32 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -70.83 -32.06 68.99 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.45 -44.13 83.65 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.7 tp -71.03 -43.1 68.6 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.224 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.58 -43.84 96.89 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.412 ' O ' HG12 ' A' ' 185' ' ' ILE . 3.2 tt -66.96 -43.82 82.1 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.5 -36.0 79.28 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.95 -0.469 . . . . 0.0 109.841 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . 0.425 ' O ' HG23 ' A' ' 187' ' ' VAL . 2.0 t -59.62 -38.95 82.68 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 2.3 t -70.26 -22.31 62.89 Favored 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.901 179.416 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.427 ' O ' HG23 ' A' ' 189' ' ' VAL . 31.0 mm -86.4 -32.29 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.191 -0.943 . . . . 0.0 110.353 179.857 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 43.1 m -77.95 -24.31 48.23 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.025 -0.422 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.436 ' N ' ' HD2' ' A' ' 188' ' ' PRO . 12.1 t -58.53 -53.95 60.96 Favored Pre-proline 0 N--CA 1.504 2.236 0 O-C-N 121.195 -0.941 . . . . 0.0 110.977 179.877 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 187' ' ' VAL . 46.6 Cg_endo -68.16 -15.45 42.86 Favored 'Trans proline' 0 N--CA 1.496 1.63 0 O-C-N 123.201 1.106 . . . . 0.0 112.806 -179.935 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 185' ' ' ILE . 77.8 t -63.34 -43.21 98.49 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.363 -0.836 . . . . 0.0 109.675 179.677 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.8 m -67.43 -33.46 75.21 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.731 -0.606 . . . . 0.0 110.18 179.472 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -72.89 -13.75 61.34 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.953 -0.467 . . . . 0.0 111.46 179.458 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -70.26 -20.64 63.04 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.458 -0.776 . . . . 0.0 111.927 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -60.19 -23.55 64.08 Favored 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.176 -0.953 . . . . 0.0 111.904 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.8 p -50.84 -38.15 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 O-C-N 121.601 -0.687 . . . . 0.0 111.782 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.559 -0.734 . . . . 0.0 109.248 179.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 120.761 0.315 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -109.9 124.99 52.32 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.551 -0.718 . . . . 0.0 110.097 -179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -171.43 -101.21 0.14 Allowed Glycine 0 N--CA 1.497 2.708 0 N-CA-C 110.471 -1.052 . . . . 0.0 110.471 -179.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -68.04 134.8 91.7 Favored Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.823 -0.81 . . . . 0.0 110.98 -179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -77.8 9.2 3.06 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 O-C-N 123.695 1.366 . . . . 0.0 112.496 179.761 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -108.06 -19.24 13.56 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.061 -1.024 . . . . 0.0 111.175 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.465 ' HA ' ' HB2' ' A' ' 178' ' ' LEU . 0.3 OUTLIER -60.34 -33.57 72.6 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.573 -0.704 . . . . 0.0 110.626 179.763 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' ILE . . . . . 0.429 HG13 ' N ' ' A' ' 177' ' ' PHE . 30.2 pt -61.33 -37.61 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.354 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' PHE . . . . . 0.429 ' N ' HG13 ' A' ' 176' ' ' ILE . 0.5 OUTLIER -79.5 -33.41 42.16 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 178.951 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.465 ' HB2' ' HA ' ' A' ' 175' ' ' SER . 11.7 mt -67.42 -43.82 80.29 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 179.401 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.83 -46.27 69.01 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.6 -40.84 88.81 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.205 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -76.42 -32.31 58.42 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.987 -0.445 . . . . 0.0 109.926 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.565 ' HA ' ' CG1' ' A' ' 185' ' ' ILE . 0.1 OUTLIER -57.47 -40.8 79.33 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.832 -0.542 . . . . 0.0 110.832 179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -62.18 -35.84 80.07 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.544 -0.722 . . . . 0.0 109.515 179.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' CYS . . . . . . . . . . . . . 4.9 t -76.04 -31.98 59.11 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 122.2 -0.312 . . . . 0.0 110.931 179.518 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.565 ' CG1' ' HA ' ' A' ' 182' ' ' LEU . 4.6 pt -90.52 -1.6 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -179.765 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 35.2 m -46.46 -45.02 17.93 Favored 'General case' 0 N--CA 1.512 2.631 0 CA-C-N 119.448 1.022 . . . . 0.0 112.024 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.486 ' HB ' ' HD3' ' A' ' 188' ' ' PRO . 40.3 t -76.23 -55.93 1.66 Allowed Pre-proline 0 N--CA 1.5 2.062 0 O-C-N 121.39 -0.819 . . . . 0.0 110.76 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.553 ' HG2' ' HA ' ' A' ' 185' ' ' ILE . 49.2 Cg_endo -69.86 -1.46 8.59 Favored 'Trans proline' 0 N--CA 1.499 1.823 0 C-N-CA 121.059 1.173 . . . . 0.0 114.109 -179.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.89 -40.64 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.419 0 CA-C-N 119.668 1.122 . . . . 0.0 112.046 -179.646 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 37.7 m -70.08 -34.6 73.38 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.774 -0.579 . . . . 0.0 110.071 179.722 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' ALA . . . . . . . . . . . . . . . -71.92 -24.66 61.67 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 122.097 -0.377 . . . . 0.0 110.522 179.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -82.48 -39.36 22.59 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.897 -0.502 . . . . 0.0 110.145 179.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.09 -34.51 78.58 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.632 -0.668 . . . . 0.0 110.705 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.743 HG13 ' HE2' ' A' ' 195' ' ' LYS . 7.4 p -77.05 -25.52 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 121.488 -0.757 . . . . 0.0 111.189 179.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.743 ' HE2' HG13 ' A' ' 194' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.979 0 CA-C-O 118.745 -0.645 . . . . 0.0 110.087 179.777 . . . . . . . . 2 2 . 1 stop_ save_